ALBEMARLE CORP - FORM 10-Q

Attached files

Attached files

Stock widget

Investing forum

ALBEMARLE CORP Reports

file	filename
EX-32.2 - EXHIBIT 32.2 - ALBEMARLE CORP	exhibit3220331201710q.htm
EX-32.1 - EXHIBIT 32.1 - ALBEMARLE CORP	exhibit3210331201710q.htm
EX-31.2 - EXHIBIT 31.2 - ALBEMARLE CORP	exhibit3120331201710q.htm
EX-31.1 - EXHIBIT 31.1 - ALBEMARLE CORP	exhibit3110331201710q.htm

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D. C. 20549

_________________________

FORM 10-Q

_________________________



x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For Quarterly Period Ended March 31, 2017



¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 1-12658

_________________________

ALBEMARLE CORPORATION

(Exact name of registrant as specified in its charter)

_________________________



VIRGINIA		54-1692118
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

4350 CONGRESS STREET, SUITE 700 CHARLOTTE, NORTH CAROLINA		28209
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code - (980) 299-5700

_________________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

Number of shares of common stock, $.01 par value, outstanding as of April 26, 2017: 110,752,288

Table of Contents

ALBEMARLE CORPORATION

INDEX – FORM 10-Q




		Page Number(s)
PART I.	FINANCIAL INFORMATION

Item 1.	Financial Statements (Unaudited)

	Consolidated Statements of Income - Three Months Ended March 31, 2017 and 2016	3

	Consolidated Statements of Comprehensive Income - Three Months Ended March 31, 2017 and 2016	4

	Condensed Consolidated Balance Sheets - March 31, 2017 and December 31, 2016	5

	Consolidated Statements of Changes in Equity - Three Months Ended March 31, 2017 and 2016	6

	Condensed Consolidated Statements of Cash Flows - Three Months Ended March 31, 2017 and 2016	7

	Notes to the Condensed Consolidated Financial Statements	8-23

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	23-36

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	36

Item 4.	Controls and Procedures	36

PART II.	OTHER INFORMATION

Item 1.	Legal Proceedings	37

Item 1A.	Risk Factors	37

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	37

Item 6.	Exhibits	38

SIGNATURES		39

EXHIBITS

Table of Contents

PART I. FINANCIAL INFORMATION



Item 1.	Financial Statements (Unaudited).

ALBEMARLE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(In Thousands, Except Per Share Amounts)

(Unaudited)



	Three Months Ended March 31,
	2017			2016
Net sales	$	722,063		$	657,211
Cost of goods sold	466,975			414,677
Gross profit	255,088			242,534
Selling, general and administrative expenses	108,001			82,631
Research and development expenses	24,323			19,872
Gain on sales of businesses, net	—			(121,324		)
Acquisition and integration related costs	—			18,558
Operating profit	122,764			242,797
Interest and financing expenses	(68,513		)	(15,114		)
Other (expenses) income, net	(794		)	47
Income from continuing operations before income taxes and equity in net income of unconsolidated investments	53,457			227,730
Income tax expense	11,971			25,485
Income from continuing operations before equity in net income of unconsolidated investments	41,486			202,245
Equity in net income of unconsolidated investments (net of tax)	21,171			15,991
Net income from continuing operations	62,657			218,236
Income from discontinued operations (net of tax)	—			17,312
Net income	62,657			235,548
Net income attributable to noncontrolling interests	(11,444		)	(7,362		)
Net income attributable to Albemarle Corporation	$	51,213		$	228,186
Basic earnings per share:
Continuing operations	$	0.46		$	1.88
Discontinued operations	—			0.15
	$	0.46		$	2.03
Diluted earnings per share:
Continuing operations	$	0.45		$	1.87
Discontinued operations	—			0.15
	$	0.45		$	2.02
Weighted-average common shares outstanding – basic	111,986			112,260
Weighted-average common shares outstanding – diluted	113,289			112,770
Cash dividends declared per share of common stock	$	0.32		$	0.305

See accompanying Notes to the Condensed Consolidated Financial Statements.

Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In Thousands)

(Unaudited)



	Three Months Ended March 31,
	2017			2016
Net income	$	62,657		$	235,548
Other comprehensive income (loss), net of tax:
Foreign currency translation	79,055			98,906
Pension and postretirement benefits	(7		)	1
Net investment hedge	(13,685		)	(9,524		)
Interest rate swap	529			525
Total other comprehensive income, net of tax	65,892			89,908
Comprehensive income	128,549			325,456
Comprehensive income attributable to noncontrolling interests	(11,905		)	(7,645		)
Comprehensive income attributable to Albemarle Corporation	$	116,644		$	317,811

See accompanying Notes to the Condensed Consolidated Financial Statements.

Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In Thousands)

(Unaudited)



	March 31,			December 31,
	2017			2016
Assets
Current assets:
Cash and cash equivalents	$	1,254,536		$	2,269,756
Trade accounts receivable, less allowance for doubtful accounts (2017 – $15,403; 2016 – $15,312)	508,460			486,035
Other accounts receivable	54,486			41,985
Inventories	518,936			450,263
Other current assets	53,836			58,579
Total current assets	2,390,254			3,306,618
Property, plant and equipment, at cost	3,965,656			3,910,522
Less accumulated depreciation and amortization	1,584,276			1,550,382
Net property, plant and equipment	2,381,380			2,360,140
Investments	493,406			457,533
Other assets	146,497			142,320
Goodwill	1,544,574			1,540,032
Other intangibles, net of amortization	410,357			354,564
Total assets	$	7,366,468		$	8,161,207
Liabilities And Equity
Current liabilities:
Accounts payable	$	336,890		$	281,874
Accrued expenses	253,930			322,165
Current portion of long-term debt	314,500			247,544
Dividends payable	35,215			34,104
Income taxes payable	267,412			254,416
Total current liabilities	1,207,947			1,140,103
Long-term debt	1,398,386			2,121,718
Postretirement benefits	50,619			50,538
Pension benefits	301,304			298,695
Other noncurrent liabilities	201,884			194,810
Deferred income taxes	422,356			412,739
Commitments and contingencies (Note 11)
Equity:
Albemarle Corporation shareholders’ equity:
Common stock, $.01 par value, issued and outstanding – 110,752 in 2017 and 112,524 in 2016	1,108			1,125
Additional paid-in capital	1,845,839			2,084,418
Accumulated other comprehensive loss	(346,981		)	(412,412		)
Retained earnings	2,137,703			2,121,931
Total Albemarle Corporation shareholders’ equity	3,637,669			3,795,062
Noncontrolling interests	146,303			147,542
Total equity	3,783,972			3,942,604
Total liabilities and equity	$	7,366,468		$	8,161,207

See accompanying Notes to the Condensed Consolidated Financial Statements.

Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

(Unaudited)



(In Thousands, Except Share Data)						Additional Paid-in Capital			Accumulated Other Comprehensive (Loss) Income			Retained Earnings			Total Albemarle Shareholders’ Equity			Noncontrolling Interests			Total Equity
	Common Stock
	Shares		Amounts
Balance at January 1, 2017	112,523,790		$	1,125		$	2,084,418		$	(412,412	)	$	2,121,931		$	3,795,062		$	147,542		$	3,942,604
Net income												51,213			51,213			11,444			62,657
Other comprehensive income									65,431						65,431			461			65,892
Cash dividends declared												(35,441		)	(35,441		)	—			(35,441		)
Stock-based compensation and other						3,945									3,945						3,945
Exercise of stock options	37,146		—			2,170									2,170						2,170
Shares repurchased	(1,948,178	)	(19		)	(249,981		)				—			(250,000		)				(250,000		)
Issuance of common stock, net	225,559		2			(2		)							—						—
Termination of Tianqi Lithium Corporation option agreement						13,144									13,144			(13,144		)	—
Shares withheld for withholding taxes associated with common stock issuances	(86,117	)	—			(7,855		)							(7,855		)				(7,855		)
Balance at March 31, 2017	110,752,200		$	1,108		$	1,845,839		$	(346,981	)	$	2,137,703		$	3,637,669		$	146,303		$	3,783,972

Balance at January 1, 2016	112,219,351		$	1,122		$	2,059,151		$	(421,288	)	$	1,615,407		$	3,254,392		$	146,921		$	3,401,313
Net income												228,186			228,186			7,362			235,548
Other comprehensive income									89,625						89,625			283			89,908
Cash dividends declared												(34,251		)	(34,251		)	—			(34,251		)
Stock-based compensation and other						4,517									4,517						4,517
Tax deficiency related to stock plans						(195		)							(195		)				(195		)
Issuance of common stock, net	112,624		1			(1		)							—						—
Shares withheld for withholding taxes associated with common stock issuances	(35,176	)	—			(1,969		)							(1,969		)				(1,969		)
Balance at March 31, 2016	112,296,799		$	1,123		$	2,061,503		$	(331,663	)	$	1,809,342		$	3,540,305		$	154,566		$	3,694,871

See accompanying Notes to the Condensed Consolidated Financial Statements.

Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Thousands)

(Unaudited)



	Three Months Ended March 31,
	2017			2016
Cash and cash equivalents at beginning of year	$	2,269,756		$	213,734
Cash flows from operating activities:
Net income	62,657			235,548
Adjustments to reconcile net income to cash flows from operating activities:
Depreciation and amortization	45,070			60,552
Gain on acquisition	(7,433		)	—
Gain on sales of businesses, net	—			(121,324		)
Stock-based compensation	5,046			4,007
Equity in net income of unconsolidated investments (net of tax)	(21,171		)	(16,566		)
Dividends received from unconsolidated investments and nonmarketable securities	2,551			200
Pension and postretirement (benefit) expense	(26		)	1,389
Pension and postretirement contributions	(2,891		)	(4,224		)
Unrealized (gain) loss on investments in marketable securities	(873		)	1,044
Loss on early extinguishment of debt	52,801			—
Deferred income tax expense	1,363			816
Working capital changes	(63,325		)	10,467
Other, net	8,816			799
Net cash provided by operating activities	82,585			172,708
Cash flows from investing activities:
Acquisitions, net of cash acquired	(27,742		)	—
Cash payments related to acquisitions and other	—			(81,988		)
Capital expenditures	(54,143		)	(58,120		)
Cash proceeds from divestitures, net	—			307,165
Sales of marketable securities, net	492			1,191
Repayments from joint ventures	1,250			—
Net cash (used in) provided by investing activities	(80,143		)	168,248
Cash flows from financing activities:
Repayments of long-term debt	(751,209		)	(331,595		)
Other borrowings, net	66,384			68,829
Fees related to early extinguishment of debt	(46,959		)	—
Dividends paid to shareholders	(34,330		)	(32,541		)
Repurchases of common stock	(250,000		)	—
Proceeds from exercise of stock options	2,170			—
Withholding taxes paid on stock-based compensation award distributions	(7,855		)	(1,969		)
Net cash used in financing activities	(1,021,799		)	(297,276		)
Net effect of foreign exchange on cash and cash equivalents	4,137			(5,032		)
(Decrease) increase in cash and cash equivalents	(1,015,220		)	38,648
Cash and cash equivalents at end of period	$	1,254,536		$	252,382

See accompanying Notes to the Condensed Consolidated Financial Statements.

Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

NOTE 1—Basis of Presentation:

In the opinion of management, the accompanying unaudited condensed consolidated financial statements of Albemarle Corporation and our wholly-owned, majority-owned and controlled subsidiaries (collectively, “Albemarle,” “we,” “us,” “our” or “the Company”) contain all adjustments necessary for a fair statement, in all material respects, of our condensed consolidated balance sheets as of March 31, 2017 and December 31, 2016, our consolidated statements of income, consolidated statements of comprehensive income, consolidated statements of changes in equity and condensed consolidated statements of cash flows for the three-month periods ended March 31, 2017 and 2016. Income tax expense for the three-month period ended March 31, 2017 includes income tax expense of $5.1 million due to an adjustment in the Company's deferred tax liabilities for basis differences in Chilean fixed assets related to the three-month period ended September 30, 2016. The Company does not believe this adjustment is material to the consolidated financial statements for the three-month period ended March 31, 2017, the three- or nine-month periods ended September 30, 2016, or the year ended December 31, 2016. All other adjustments are of a normal and recurring nature. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2016, which was filed with the Securities and Exchange Commission (“SEC”) on February 28, 2017. The December 31, 2016 condensed consolidated balance sheet data herein was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles (“GAAP”) in the United States (“U.S.”). The results of operations for the three-month period ended March 31, 2017 are not necessarily indicative of the results to be expected for the full year. Certain reclassifications have been made to the accompanying condensed consolidated financial statements and the notes thereto to conform to the current presentation. In addition, for the three-month period ended March 31, 2017, the Company began reporting its acquisition and integration related costs and restructuring and other costs in Cost of goods sold, Selling, general and administrative expenses and Research and development expenses. See Note 2, “Acquisitions,” and Note 12, “Segment Information,” for further details.

As described further in Note 3, “Divestitures,” on December 14, 2016, the Company closed the sale of its Chemetall^® Surface Treatment business to BASF SE. Financial results of this business have been presented as discontinued operations in the consolidated statements of income and excluded from segment results for the three-month period ended March 31, 2016.

NOTE 2—Acquisitions:

On December 31, 2016, we completed the acquisition of all equity interests in the lithium hydroxide and lithium carbonate conversion business of Jiangxi Jiangli New Materials Science and Technology Co. Ltd. (“Jiangli New Materials”) for a cash purchase price of approximately $145 million. This includes manufacturing assets located in both Jiangxi and Sichuan, China focused on the production of battery-grade lithium carbonate and lithium hydroxide. This acquisition will enable us to supply premium lithium salts to an expanded global customer base while solidifying our leading position in the lithium industry.

The aggregate purchase price was allocated to the major categories of assets and liabilities acquired based upon their estimated fair values as of December 31, 2016, which were based, in part, upon outside preliminary appraisals for certain assets. The preliminary estimated fair values of the assets and liabilities acquired were primarily related to Property, plant and equipment of $29.0 million, Other intangibles of $32.0 million and Deferred tax liabilities of $3.9 million. In addition, the estimated fair value of net working capital acquired was $6.2 million, however, an equal liability was recorded in Accrued expenses, as it will be repaid to the previous owners of the acquired business. The excess of the purchase price over the preliminary estimated fair value of the net assets acquired was approximately $87.9 million and was recorded as goodwill. The allocation of the purchase price to the assets acquired and liabilities assumed, including the residual amount allocated to goodwill, is based upon preliminary information and is subject to change within the measurement period (up to one year from the acquisition date) as additional information concerning final asset and liability valuations is obtained. The primary areas of the preliminary purchase price allocation that are not yet finalized relate to the property, plant and equipment, other intangible assets, deferred income taxes, as well as various working capital accounts. The fair values of the assets acquired and liabilities assumed are based on management’s preliminary estimates and assumptions, as well as other information compiled by management, including valuations that utilize customary valuation procedures and techniques. While the Company believes that such preliminary estimates provide a reasonable basis for estimating the fair value of assets acquired and liabilities assumed, it will evaluate any necessary information prior to finalization of the amounts. During the measurement period, the Company will adjust assets or liabilities if new information is obtained about facts and circumstances that existed as of the acquisition date that, if known, would have resulted in revised estimated values of those assets or liabilities as of that date.

Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

During the three-month period ended March 31, 2017, the Company purchased inventory with a fair value of $37.0 million in connection with the Jiangli New Materials acquisition, $19.4 million of which was paid during the first quarter. The fair value included the markup of the underlying book value of $23.0 million. The inventory markup is being expensed over the estimated remaining selling period, with $10.6 million recorded in the three-month period ended March 31, 2017.

Goodwill arising from the acquisition consists largely of the anticipated synergies and economies of scale from the combined assets and the overall strategic importance of the acquired assets to Albemarle. The goodwill attributable to the acquisition will not be amortizable or deductible for tax purposes. The weighted-average amortization periods for the other intangible assets acquired are 20 years for patents and technology, 18 years for customer lists and relationships and 3 years for other. The weighted-average amortization period for all definite-lived intangible assets acquired is 17 years.

On February 1, 2017, the Company acquired the remaining 50% interest in the Sales de Magnesio Ltda. (“Salmag”) joint venture in Chile from SQM Salar S.A. for approximately $8.3 million, net of cash acquired. In connection with the acquisition, the Company recorded a gain of $7.4 million, calculated based on the difference between the purchase price and the book value of the investment in Other (expenses) income, net on the consolidated statements of income for the three-month period ended March 31, 2017. The calculation of the gain and the fair values of the assets acquired and liabilities assumed are based on management’s preliminary estimates and assumptions. While the Company believes that such preliminary estimates provide a reasonable basis for estimating the fair value of assets acquired and liabilities assumed, it will evaluate any necessary information prior to finalization of the amounts.

Acquisition and integration related costs of $8.9 million and $5.4 million were included in Cost of goods sold and Selling, general and administrative expenses, respectively, on our consolidated statements of income for the three-month period ended March 31, 2017, primarily resulting from the Jiangli New Materials acquisition, including unusual compensation related costs negotiated specifically as a result of this acquisition that are outside of the Company’s normal compensation arrangements. Included in Acquisition and integration related costs on our consolidated statements of income for the the three-month period ended March 31, 2016 were $16.9 million of integration costs resulting from the acquisition of Rockwood Holdings, Inc. (mainly consisting of professional services and advisory fees, costs to achieve synergies, relocation costs, and other integration costs) and $1.7 million of costs in connection with other significant projects.

NOTE 3—Divestitures:

Discontinued Operations

On June 17, 2016, we entered into a definitive agreement to sell the Chemetall Surface Treatment business to BASF SE. On December 14, 2016, the Company closed the sale of this business and received proceeds of approximately $3.1 billion, net of purchase price adjustments. The sale of the Chemetall Surface Treatment business, a separate reportable segment, qualified for discontinued operations treatment because it represented a strategic shift that will have a major effect on the Company’s operations and financial results. As a result, the Company accounted for this business as discontinued operations in the consolidated statements of income and excluded the business from segment results for the three-month period ended March 31, 2016. The Company stopped recording depreciation and amortization expense on assets of the Chemetall Surface Treatment business as of the date this business qualified for discontinued operations treatment, in the second quarter of 2016.

The major components of Income from discontinued operations (net of tax) for the three-month period ended March 31, 2016 were as follows (in thousands):



	Three Months Ended March 31, 2016
Net sales	$	208,187
Cost of goods sold	113,323
Operating expenses, net	62,853
Interest and financing expenses^(a)	10,137
Other income, net	(938		)
Income before income taxes	22,812
Income tax expense	5,500
Income from discontinued operations (net of tax)	$	17,312

Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)


(a)	Interest and financing expenses included the allocation of interest expense not directly attributable to other operations as well as interest expense related to debt to be assumed by the buyer. The allocation of interest expense to discontinued operations was based on the ratio of net assets held for sale to the sum of total net assets plus consolidated debt.

Depreciation and amortization and capital expenditures from discontinued operations for the three-month period ended March 31, 2016 were as follows (in thousands):



	Three Months Ended March 31, 2016
Depreciation and amortization	$	16,943
Capital expenditures	$	5,747

Other Divestitures

On November 5, 2015, the Company signed a definitive agreement to sell its Tribotecc metal sulfides business to Treibacher Industrie AG. Included in the transaction were sites in Vienna and Arnoldstein, Austria, and Tribotecc’s proprietary sulfide synthesis process. On January 4, 2016, the Company closed the sale of this business, effective for the first day of business in 2016. We received net proceeds of approximately $137 million and recorded a gain of $11.5 million before income taxes in the first quarter of 2016 related to the sale of this business.

On December 16, 2015, the Company signed a definitive agreement to sell its minerals-based flame retardants and specialty chemicals business to Huber Engineered Materials, a division of J.M. Huber Corporation. The transaction included Albemarle’s Martinswerk GmbH subsidiary and manufacturing facility located in Bergheim, Germany, and Albemarle’s 50% ownership interest in Magnifin Magnesiaprodukte GmbH, a joint-venture with Radex Heraklith Industriebeteiligung AG at Breitenau, Austria. On February 1, 2016, the Company closed the sale of these businesses. We received net proceeds of approximately $187 million and recorded a gain of $111.3 million before income taxes in the first quarter of 2016 related to the sale of these businesses.

Also included in Gain on sales of businesses, net, for the first quarter of 2016 was a loss of $1.5 million on the sale of our wafer reclaim business.

These businesses did not qualify for discontinued operations treatment because the Company’s management did not consider their sale as representing a strategic shift that had or will have a major effect on the Company’s operations and financial results.

NOTE 4—Goodwill and Other Intangibles:

The following table summarizes the changes in goodwill by reportable segment for the three months ended March 31, 2017 (in thousands):



	Lithium and Advanced Materials			Bromine Specialties		Refining Solutions		All Other		Total
Balance at December 31, 2016	$	1,348,261		$	20,319	$	164,866	$	6,586	$	1,540,032
Acquisitions^(a)	(21,822		)	—		—		—		(21,822		)
Foreign currency translation adjustments	20,694			—		5,670		—		26,364
Balance at March 31, 2017	$	1,347,133		$	20,319	$	170,536	$	6,586	$	1,544,574


(a)	Primarily represents preliminary purchase price adjustments for the Jiangli New Materials acquisition. See Note 2, “Acquisitions,” for additional information.

Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

The following table summarizes the changes in other intangibles and related accumulated amortization for the three months ended March 31, 2017 (in thousands):



	Customer Lists and Relationships			Trade Names and Trademarks^(a)			Patents and Technology			Other			Total
Gross Asset Value
Balance at December 31, 2016	$	387,893		$	16,514		$	38,434		$	18,844		$	461,685
Acquisitions^(b)	1,717			—			25,555			19,917			47,189
Foreign currency translation adjustments and other	10,340			264			514			1,774			12,892
Balance at March 31, 2017	$	399,950		$	16,778		$	64,503		$	40,535		$	521,766
Accumulated Amortization
Balance at December 31, 2016	$	(49,165	)	$	(7,952	)	$	(31,683	)	$	(18,321	)	$	(107,121	)
Amortization	(4,801		)	—			(413		)	(526		)	(5,740		)
Foreign currency translation adjustments and other	(1,164		)	(94		)	(503		)	3,213			1,452
Balance at March 31, 2017	$	(55,130	)	$	(8,046	)	$	(32,599	)	$	(15,634	)	$	(111,409	)
Net Book Value at December 31, 2016	$	338,728		$	8,562		$	6,751		$	523		$	354,564
Net Book Value at March 31, 2017	$	344,820		$	8,732		$	31,904		$	24,901		$	410,357


(a)	Balances as of March 31, 2017 and December 31, 2016 include only indefinite-lived intangible assets.


(b)	Represents preliminary purchase price adjustments for the Jiangli New Materials acquisition and the acquisition of the remaining equity interest in Salmag. See Note 2, “Acquisitions,” for additional information.

NOTE 5—Foreign Exchange:

Foreign exchange transaction losses were $4.9 million and $0.1 million for the three-month periods ended March 31, 2017 and 2016, respectively, and were included in Other (expenses) income, net, in our consolidated statements of income, with the unrealized portion included in Other, net, in our condensed consolidated statements of cash flows.

NOTE 6—Income Taxes:

The effective income tax rate for the three-month period ended March 31, 2017 was 22.4%, compared to 11.2% for the three-month period ended March 31, 2016. The Company’s effective income tax rate fluctuates based on, among other factors, its level and location of income. The difference between the U.S. federal statutory income tax rate and our effective income tax rate for the 2017 and 2016 periods was primarily due to the impact of earnings from outside the U.S., and is mainly attributable to our share of the income of our Jordan Bromine Company Limited (“JBC”) joint venture, a Free Zones company under the laws of the Hashemite Kingdom of Jordan. In addition, Income tax expense for the three-month period ended March 31, 2017 included a $5.1 million out-of-period adjustment as described in Note 1, "Basis of Presentation," partially offset by a $4.1 million reduction from the tax effects of share-based compensation awards. Our effective tax rate for the three-month period ended March 31, 2016 was driven down by a variety of factors, primarily low tax gains from the sale of the minerals-based flame retardant business, as well as a favorable mix of earnings in lower tax jurisdictions.

Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

NOTE 7—Earnings Per Share:

Basic and diluted earnings per share from continuing operations for the three-month periods ended March 31, 2017 and 2016 are calculated as follows (in thousands, except per share amounts):



	Three Months Ended March 31,
	2017			2016
Basic earnings per share from continuing operations
Numerator:
Net income from continuing operations	$	62,657		$	218,236
Net income from continuing operations attributable to noncontrolling interests	(11,444		)	(7,362		)
Net income from continuing operations attributable to Albemarle Corporation	$	51,213		$	210,874
Denominator:
Weighted-average common shares for basic earnings per share	111,986			112,260
Basic earnings per share from continuing operations	$	0.46		$	1.88

Diluted earnings per share from continuing operations
Numerator:
Net income from continuing operations	$	62,657		$	218,236
Net income from continuing operations attributable to noncontrolling interests	(11,444		)	(7,362		)
Net income from continuing operations attributable to Albemarle Corporation	$	51,213		$	210,874
Denominator:
Weighted-average common shares for basic earnings per share	111,986			112,260
Incremental shares under stock compensation plans	1,303			510
Weighted-average common shares for diluted earnings per share	113,289			112,770
Diluted earnings per share from continuing operations	$	0.45		$	1.87

On February 23, 2017, the Company increased the regular quarterly dividend by 5% to $0.32 per share and declared a cash dividend of said amount for the first quarter of 2017, which was paid on April 3, 2017 to shareholders of record at the close of business as of March 15, 2017.

Under our existing Board authorized share repurchase program, the Company entered into an accelerated share repurchase (“ASR”) agreement with a financial institution on March 1, 2017. Under the ASR agreement, in March 2017, the Company paid $250 million from available cash on hand and received and retired an initial delivery of 1,948,178 shares of our common stock with a fair market value of $200 million, which reduced the Company’s weighted average shares outstanding for purposes of calculating basic and diluted earnings per share for the three-month period ended March 31, 2017. The total number of shares to ultimately be delivered under the ASR agreement will be determined upon completion of the ASR agreement, which will be by the end of the second quarter of 2017, and will generally be based on the daily Rule 10b-18 volume-weighted average prices of the Company’s common stock over the term of the ASR agreement, less an agreed discount. The Company has determined that the ASR agreement meets the criteria to be accounted for as a forward contract indexed to its stock and is therefore being treated as an equity instrument. Although the ASR agreement can be settled, at the Company’s option, in cash or in shares of common stock, the Company intends to settle in shares of common stock.

No more than 15,000,000 shares can be repurchased under the Company’s authorized share repurchase program. As of March 31, 2017, there were 13,051,822 remaining shares available for repurchase under the Company’s authorized share repurchase program.

Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

NOTE 8—Inventories:

The following table provides a breakdown of inventories at March 31, 2017 and December 31, 2016 (in thousands):



	March 31,		December 31,
	2017		2016
Finished goods	$	345,892	$	289,102
Raw materials and work in process^(a)	120,759		109,706
Stores, supplies and other	52,285		51,455
Total inventories	$	518,936	$	450,263


(a)	Included $50.1 million and $47.1 million at March 31, 2017 and December 31, 2016, respectively, of work in process related to the Lithium product category.

NOTE 9—Investments:

The Company holds a 49% equity interest in Windfield Holdings Pty. Ltd. (“Windfield”). With regard to the Company’s ownership in Windfield, the parties share risks and benefits disproportionate to their voting interests. As a result, the Company considers Windfield to be a variable interest entity (“VIE”). However, the Company does not consolidate Windfield as it is not the primary beneficiary. The carrying amount of our 49% equity interest in Windfield, which is our most significant VIE, was $318.8 million and $288.6 million at March 31, 2017 and December 31, 2016, respectively. The Company’s aggregate net investment in all other entities which it considers to be VIE’s for which the Company is not the primary beneficiary was $9.1 million and $8.8 million at March 31, 2017 and December 31, 2016, respectively. Our unconsolidated VIE’s are reported in Investments in the condensed consolidated balance sheets. The Company does not guarantee debt for, or have other financial support obligations to, these entities, and its maximum exposure to loss in connection with its continuing involvement with these entities is limited to the carrying value of the investments.

As part of the original Windfield joint venture agreement, Tianqi Lithium Corporation ("Tianqi") was granted an option to purchase from 20% to 30% of the equity interests in Rockwood Lithium GmbH, a wholly-owned German subsidiary of Albemarle, and its subsidiaries. In February 2017, Albemarle and Tianqi terminated the option agreement, and as a result, we will retain 100% of the ownership interest in Rockwood Lithium GmbH and its subsidiaries. Following the termination of the option agreement, the $13.1 million fair value of the option agreement originally recorded in Noncontrolling interests was reversed and recorded as an adjustment to Additional paid-in capital.

NOTE 10—Long-Term Debt:

Long-term debt at March 31, 2017 and December 31, 2016 consisted of the following (in thousands):



	March 31,		December 31,
	2017		2016
1.875% Senior notes, net of unamortized discount and debt issuance costs of $4,305 at March 31, 2017 and $7,823 at December 31, 2016	$	418,471	$	719,617
3.00% Senior notes, net of unamortized discount and debt issuance costs of $1,286 at December 31, 2016	—		248,714
4.15% Senior notes, net of unamortized discount and debt issuance costs of $3,737 at March 31, 2017 and $3,859 at December 31, 2016	421,262		421,141
4.50% Senior notes, net of unamortized discount and debt issuance costs of $1,116 at March 31, 2017 and $2,380 at December 31, 2016	174,098		347,620
5.45% Senior notes, net of unamortized discount and debt issuance costs of $4,274 at March 31, 2017 and $4,313 at December 31, 2016	345,726		345,687
Commercial paper notes	314,500		247,503
Variable-rate foreign bank loans	38,829		38,939
Miscellaneous	—		41
Total long-term debt	1,712,886		2,369,262
Less amounts due within one year	314,500		247,544
Long-term debt, less current portion	$	1,398,386	$	2,121,718

In the three-month period ended March 31, 2017, using a portion of the proceeds from the sale of the Chemetall Surface Treatment business, we repaid the 3.00% Senior notes in full, €307.0 million of the 1.875% Senior notes and $174.7 million of

Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

the 4.50% Senior notes, as well as related tender premiums of $45.2 million. As a result, during the three-month period ended March 31, 2017, we recorded a loss on early extinguishment of debt of $52.8 million in Interest and financing expenses on the consolidated statements of income, representing the tender premiums, fees, unamortized discounts and unamortized deferred financings costs from the redemption of these senior notes.

Current portion of long-term debt at March 31, 2017 consisted of commercial paper notes with a weighted-average interest rate of approximately 1.54% and a weighted-average maturity of 29 days.

The carrying value of our 1.875% Euro-denominated senior notes has been designated as an effective hedge of our net investment in certain foreign subsidiaries where the Euro serves as the functional currency, and gains or losses on the revaluation of these senior notes to our reporting currency are recorded in accumulated other comprehensive loss. During the three-month periods ended March 31, 2017 and 2016, losses of $13.7 million and $9.5 million (net of income taxes), respectively, were recorded in accumulated other comprehensive loss in connection with the revaluation of these senior notes to our reporting currency.

NOTE 11—Commitments and Contingencies:

Environmental

We had the following activity in our recorded environmental liabilities for the three months ended March 31, 2017, as follows (in thousands):



Beginning balance at December 31, 2016	$	34,919
Expenditures	(303		)
Accretion of discount	183
Foreign currency translation adjustments and other	640
Ending balance at March 31, 2017	35,439
Less amounts reported in Accrued expenses	2,345
Amounts reported in Other noncurrent liabilities	$	33,094

Environmental remediation liabilities included discounted liabilities of $24.2 million and $22.8 million at March 31, 2017 and December 31, 2016, respectively, discounted at rates with a weighted-average of 3.6%, with the undiscounted amount totaling $62.1 million and $61.1 million at March 31, 2017 and December 31, 2016, respectively. For certain locations where the Company is operating groundwater monitoring and/or remediation systems, prior owners or insurers have assumed all or most of the responsibility.

The amounts recorded represent our future remediation and other anticipated environmental liabilities. These liabilities typically arise during the normal course of our operational and environmental management activities or at the time of acquisition of the site, and are based on internal analysis as well as input from outside consultants. As evaluations proceed at each relevant site, changes in risk assessment practices, remediation techniques and regulatory requirements can occur, therefore such liability estimates may be adjusted accordingly. The timing and duration of remediation activities at these sites will be determined when evaluations are completed. Although it is difficult to quantify the potential financial impact of these remediation liabilities, management estimates (based on the latest available information) that there is a reasonable possibility that future environmental remediation costs associated with our past operations, in excess of amounts already recorded, could be up to approximately $17 million before income taxes.

We believe that any sum we may be required to pay in connection with environmental remediation matters in excess of the amounts recorded would likely occur over a period of time and would likely not have a material adverse effect upon our results of operations, financial condition or cash flows on a consolidated annual basis although any such sum could have a material adverse impact on our results of operations, financial condition or cash flows in a particular quarterly reporting period.

Litigation

We are involved from time to time in legal proceedings of types regarded as common in our business, including administrative or judicial proceedings seeking remediation under environmental laws, such as the federal Comprehensive Environmental Response, Compensation and Liability Act, commonly known as CERCLA or Superfund, products liability, breach of contract liability and premises liability litigation. Where appropriate, we may establish financial reserves for such

Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

proceedings. We also maintain insurance to mitigate certain of such risks. Costs for legal services are generally expensed as incurred.

Indemnities

We are indemnified by third parties in connection with certain matters related to acquired and divested businesses. Although we believe that the financial condition of those parties who may have indemnification obligations to the Company is generally sound, in the event the Company seeks indemnity under any of these agreements or through other means, there can be no assurance that any party who may have obligations to indemnify us will adhere to their obligations and we may have to resort to legal action to enforce our rights under the indemnities.

The Company may be subject to indemnity claims relating to properties or businesses it divested, including properties or businesses of acquired businesses that were divested prior to the completion of the acquisition. In the opinion of management, and based upon information currently available, the ultimate resolution of any indemnification obligations owed to the Company or by the Company is not expected to have a material effect on the Company’s financial condition, results of operations or cash flows. The Company had approximately $39.5 million and $38.2 million at March 31, 2017 and December 31, 2016, respectively, recorded in Other noncurrent liabilities related to the indemnification of certain income and non-income tax liabilities associated with the Chemetall Surface Treatment entities sold.

Other

We have contracts with certain of our customers, which serve as guarantees on product delivery and performance according to customer specifications that can cover both shipments on an individual basis as well as blanket coverage of multiple shipments under certain customer supply contracts. The financial coverage provided by these guarantees is typically based on a percentage of net sales value.

NOTE 12—Segment Information:

Our three reportable segments include Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Each segment has a dedicated team of sales, research and development, process engineering, manufacturing and sourcing, and business strategy personnel and has full accountability for improving execution through greater asset and market focus, agility and responsiveness. This structure aligns with the markets and customers we serve through each of the segments. The structure also facilitates the continued standardization of business processes across the organization, and is consistent with the manner in which information is presently used internally by the Company’s chief operating decision maker to evaluate performance and make resource allocation decisions.

Summarized financial information concerning our reportable segments is shown in the following tables.

The “All Other” category comprises operating segments that did not fit into any of our core businesses. During the first quarter of 2016, we completed the sales of the metal sulfides business and the minerals-based flame retardants and specialty chemicals businesses. For additional information about these businesses, see Note 3, “Divestitures.” Following the sales of these businesses, the “All Other” category includes only the fine chemistry services business.

The Corporate category is not considered to be a segment and includes corporate-related items not allocated to the operating segments. Pension and OPEB service cost (which represents the benefits earned by active employees during the period) and amortization of prior service cost or benefit are allocated to the reportable segments, All Other, and Corporate, whereas the remaining components of pension and OPEB benefits cost or credit (“Non-operating pension and OPEB items”) are included in Corporate. Segment data includes intersegment transfers of raw materials at cost and allocations for certain corporate costs.

The Company’s chief operating decision maker uses earnings before interest, taxes, depreciation and amortization, as adjusted on a consistent basis for certain non-recurring or unusual items such as acquisition and integration related costs, utilization of inventory markup, gains or losses on sales of businesses, restructuring charges, facility divestiture charges, non-operating pension and OPEB items and other significant non-recurring items (“adjusted EBITDA”), in a balanced manner and on a segment basis to assess the ongoing performance of the Company’s business segments and to allocate resources. In addition, management uses adjusted EBITDA for business planning purposes and as a significant component in the calculation of performance-based compensation for management and other employees. The Company has reported adjusted EBITDA because management believes it provides transparency to investors and enables period-to-period comparability of financial performance. Adjusted EBITDA is a financial measure that is not required by, or presented in accordance with, U.S. GAAP.

Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

Adjusted EBITDA should not be considered as an alternative to Net income (loss) attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with U.S. GAAP, or any other financial measure reported in accordance with U.S. GAAP.



	Three Months Ended March 31,
	2017			2016
	(In thousands)
Net sales:
Lithium and Advanced Materials	$	284,375		$	216,173
Bromine Specialties	219,191			196,553
Refining Solutions	185,412			170,579
All Other	32,419			72,089
Corporate	666			1,817
Total net sales	$	722,063		$	657,211

Adjusted EBITDA:
Lithium and Advanced Materials	$	120,022		$	86,474
Bromine Specialties	68,488			61,608
Refining Solutions	49,579			55,074
All Other	5,156			8,464
Corporate	(31,869		)	(19,587		)
Total adjusted EBITDA	$	211,376		$	192,033

Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

See below for a reconciliation of adjusted EBITDA, the non-GAAP financial measure, from Net income (loss) attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with U.S. GAAP (in thousands):



	Lithium and Advanced Materials			Bromine Specialties		Refining Solutions		Reportable Segments Total			All Other			Corporate			Consolidated Total
Three months ended March 31, 2017
Net income (loss) attributable to Albemarle Corporation	$	94,106		$	58,694	$	40,474	$	193,274		$	3,246		$	(145,307	)	$	51,213
Depreciation and amortization	22,743			9,794		9,105		41,642			1,910			1,518			45,070
Utilization of inventory markup^(a)	10,606			—		—		10,606			—			—			10,606
Restructuring and other^(b)	—			—		—		—			—			12,905			12,905
Gain on acquisition^(c)	(7,433		)	—		—		(7,433		)	—			—			(7,433		)
Acquisition and integration related costs^(d)	—			—		—		—			—			14,281			14,281
Interest and financing expenses^(e)	—			—		—		—			—			68,513			68,513
Income tax expense	—			—		—		—			—			11,971			11,971
Non-operating pension and OPEB items	—			—		—		—			—			(1,063		)	(1,063		)
Other^(f)	—			—		—		—			—			5,313			5,313
Adjusted EBITDA	$	120,022		$	68,488	$	49,579	$	238,089		$	5,156		$	(31,869	)	$	211,376
Three months ended March 31, 2016
Net income (loss) attributable to Albemarle Corporation	$	63,327		$	51,853	$	46,314	$	161,494		$	130,709		$	(64,017	)	$	228,186
Depreciation and amortization	23,147			9,755		8,760		41,662			612			1,335			43,609
(Gain) loss on sales of businesses, net^(g)	—			—		—		—			(122,857		)	1,533			(121,324		)
Acquisition and integration related costs^(d)	—			—		—		—			—			18,558			18,558
Interest and financing expenses	—			—		—		—			—			15,114			15,114
Income tax expense	—			—		—		—			—			25,485			25,485
Income from discontinued operations (net of tax)	—			—		—		—			—			(17,312		)	(17,312		)
Non-operating pension and OPEB items	—			—		—		—			—			(283		)	(283		)
Adjusted EBITDA	$	86,474		$	61,608	$	55,074	$	203,156		$	8,464		$	(19,587	)	$	192,033

(a)

In connection with the acquisition of Jiangli New Materials, the Company valued inventory purchased from Jiangli New Materials at fair value, which resulted in a markup of the underlying net book value of the inventory totaling approximately $23.0 million. The inventory markup is being expensed over the estimated remaining selling period. For the three-month period ended March 31, 2017, $10.6 million was included in Cost of goods sold related to the utilization of the inventory markup.

(b)

During the first quarter of 2017, we initiated action to reduce costs at several locations, primarily at our Lithium site in Germany. Based on the restructuring plans, we have recorded expenses of $2.9 million in Cost of goods sold, $4.2 million in Selling, general and administrative expenses and $5.8 million in Research and development expenses, primarily related to severance, expected to be incurred. The unpaid balance is recorded in Accrued expenses at March 31, 2017, with the expectation that the majority of this plan will be completed by the end of 2017.


(c)	Gain recorded in Other (expenses) income, net related to the acquisition of the remaining 50% interest in Salmag. See Note 2, “Acquisitions,” for additional information.


(d)	See Note 2, “Acquisitions,” for additional information.


(e)	Included in Interest and financing expenses is a loss on early extinguishment of debt of $52.8 million. See Note 10, “Long-term Debt,” for additional information.


(f)	Included in Other (expenses) income, net are $3.2 million of asset retirement obligation charges related to the revision of an estimate at a site formerly owned by Albemarle and a loss of $2.1 million associated with the previous disposal of a business.


(g)	See Note 3, “Divestitures,” for additional information.

Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

NOTE 13—Pension Plans and Other Postretirement Benefits:

The components of pension and postretirement benefits cost (credit) from continuing operations for the three-month periods ended March 31, 2017 and 2016 were as follows (in thousands):



	Three Months Ended March 31,
	2017			2016
Pension Benefits Cost (Credit):
Service cost	$	1,003		$	1,048
Interest cost	8,288			9,366
Expected return on assets	(9,908		)	(10,173		)
Actuarial gain	—			(50		)
Amortization of prior service benefit	27			28
Total net pension benefits (credit) cost	$	(590	)	$	219
Postretirement Benefits Cost (Credit):
Service cost	$	31		$	29
Interest cost	585			621
Expected return on assets	(28		)	(47		)
Amortization of prior service benefit	(24		)	(24		)
Total net postretirement benefits cost	$	564		$	579
Total net pension and postretirement benefits (credit) cost^(a)	$	(26	)	$	798


(a)	For the three-month period ended March 31, 2016, $0.6 million of net pension and postretirement benefits cost are included in Income from discontinued operations (net of tax) in the consolidated statements of income. See Note 3, “Divestitures,” for additional information.

During the three-month periods ended March 31, 2017 and 2016, we made contributions of $2.4 million to our qualified and nonqualified pension plans for continuing operations. Contributions to discontinued operations qualified and nonqualified pension plans were $1.0 million for the three-month period ended March 31, 2016.

We paid $0.5 million and $0.8 million in premiums to the U.S. postretirement benefit plan during the three-month periods ended March 31, 2017 and 2016, respectively.

Multiemployer Plan

Our contributions to the Pensionskasse Dynamit Nobel Versicherungsverein auf Gegenseitigkeit, Troisdorf (“DN Pensionskasse”) multiemployer plan for continuing operations were €0.2 million (approximately $0.2 million and $0.3 million) during the three-month periods ended March 31, 2017 and 2016, respectively. Contributions for discontinued operations were €0.2 million (approximately $0.2 million) during the three-month period ended March 31, 2016.

NOTE 14—Fair Value of Financial Instruments:

In assessing the fair value of financial instruments, we use methods and assumptions that are based on market conditions and other risk factors existing at the time of assessment. Fair value information for our financial instruments is as follows:

Long-Term Debt—the fair values of our senior notes are estimated using Level 1 inputs and account for the difference between the recorded amount and fair value of our long-term debt. The carrying value of our remaining long-term debt reported in the accompanying condensed consolidated balance sheets approximates fair value as substantially all of such debt bears interest based on prevailing variable market rates currently available in the countries in which we have borrowings.



	March 31, 2017				December 31, 2016
	Recorded Amount		Fair Value		Recorded Amount		Fair Value
	(In thousands)
Long-term debt	$	1,721,455	$	1,807,576	$	2,381,370	$	2,472,813

Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

Foreign Currency Forward Contracts—we enter into foreign currency forward contracts in connection with our risk management strategies in an attempt to minimize the financial impact of changes in foreign currency exchange rates. These derivative financial instruments are used to manage risk and are not used for trading or other speculative purposes. The fair values of our foreign currency forward contracts are estimated based on current settlement values. At March 31, 2017 and December 31, 2016, we had outstanding foreign currency forward contracts with notional values totaling $285.9 million and $251.6 million, respectively. Our foreign currency forward contracts outstanding at March 31, 2017 and December 31, 2016 were not designated as hedging instruments under Accounting Standards Codification (“ASC”) 815, Derivatives and Hedging. At March 31, 2017, less than $0.1 million was included in Other accounts receivable associated with the fair value of our foreign currency forward contracts, and at December 31, 2016, $0.2 million was included in Accrued expenses associated with the fair value of our foreign currency forward contracts.

Gains and losses on foreign currency forward contracts are recognized in Other (expenses) income, net; further, fluctuations in the value of these contracts are generally expected to be offset by changes in the value of the underlying exposures being hedged, which are also reported in Other (expenses) income, net. For the three-month periods ended March 31, 2017 and 2016, we recognized gains of $4.5 million and $5.8 million, respectively, in Other (expenses) income, net, in our consolidated statements of income related to the change in the fair value of our foreign currency forward contracts. Also, for the three-month periods ended March 31, 2017 and 2016, we recorded gains of $4.5 million and $5.8 million, respectively, related to the change in the fair value of our foreign currency forward contracts, and net cash receipts of $4.3 million and $5.1 million, respectively, in Other, net, in our condensed consolidated statements of cash flows.

The counterparties to our foreign currency forward contracts are major financial institutions with which we generally have other financial relationships. We are exposed to credit loss in the event of nonperformance by these counterparties. However, we do not anticipate nonperformance by the counterparties.

NOTE 15—Fair Value Measurement:

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The inputs used to measure fair value are classified into the following hierarchy:



Level 1	Unadjusted quoted prices in active markets for identical assets or liabilities

Level 2	Unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability

Level 3	Unobservable inputs for the asset or liability

We endeavor to utilize the best available information in measuring fair value. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Transfers between levels of the fair value hierarchy are deemed to have occurred on the date of the event or change in circumstance that caused the transfer. There were no transfers between Levels 1 and 2 during the three-month period ended March 31, 2017. The following tables set forth our financial assets and liabilities that were accounted for at fair value on a recurring basis as of March 31, 2017 and December 31, 2016 (in thousands):



	March 31, 2017		Quoted Prices in Active Markets for Identical Items (Level 1)		Quoted Prices in Active Markets for Similar Items (Level 2)		Unobservable Inputs (Level 3)
	March 31, 2017				Quoted Prices in Active Markets for Similar Items (Level 2)		Unobservable Inputs (Level 3)
Assets:
Investments under executive deferred compensation plan^(a)	$	22,417	$	22,417	$	—	$	—
Private equity securities^(b)	$	36	$	36	$	—	$	—
Private equity securities measured at net asset value^(b)(c)	$	5,492	$	—	$	—	$	—
Foreign currency forward contracts^(d)	$	7	$	—	$	7	$	—

Liabilities:
Obligations under executive deferred compensation plan^(a)	$	22,417	$	22,417	$	—	$	—

Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)



	December 31, 2016		Quoted Prices in Active Markets for Identical Items (Level 1)		Quoted Prices in Active Markets for Similar Items (Level 2)		Unobservable Inputs (Level 3)
	December 31, 2016				Quoted Prices in Active Markets for Similar Items (Level 2)		Unobservable Inputs (Level 3)
Assets:
Investments under executive deferred compensation plan^(a)	$	22,037	$	22,037	$	—	$	—
Private equity securities^(b)	$	35	$	35	$	—	$	—
Private equity securities measured at net asset value^(b)(c)	$	5,498	$	—	$	—	$	—

Liabilities:
Obligations under executive deferred compensation plan^(a)	$	22,037	$	22,037	$	—	$	—
Foreign currency forward contracts^(d)	$	182	$	—	$	182	$	—

(a)

We maintain an Executive Deferred Compensation Plan (“EDCP”) that was adopted in 2001 and subsequently amended. The purpose of the EDCP is to provide current tax planning opportunities as well as supplemental funds upon the retirement or death of certain of our employees. The EDCP is intended to aid in attracting and retaining employees of exceptional ability by providing them with these benefits. We also maintain a Benefit Protection Trust (the “Trust”) that was created to provide a source of funds to assist in meeting the obligations of the EDCP, subject to the claims of our creditors in the event of our insolvency. Assets of the Trust are consolidated in accordance with authoritative guidance. The assets of the Trust consist primarily of mutual fund investments (which are accounted for as trading securities and are marked-to-market on a monthly basis through the consolidated statements of income) and cash and cash equivalents. As such, these assets and obligations are classified within Level 1.


(b)	Primarily consists of private equity securities classified as available-for-sale and are reported in Investments in the condensed consolidated balance sheets. The changes in fair value are reported in Other (expenses) income, net, in our consolidated statements of income.


(c)	Holdings in private equity securities are measured at fair value using the net asset value per share (or its equivalent) practical expedient and have not been categorized in the fair value hierarchy.

(d)

As a result of our global operating and financing activities, we are exposed to market risks from changes in foreign currency exchange rates, which may adversely affect our operating results and financial position. When deemed appropriate, we minimize our risks from foreign currency exchange rate fluctuations through the use of foreign currency forward contracts. Unless otherwise noted, these derivative financial instruments are not designated as hedging instruments under ASC 815, Derivatives and Hedging. The foreign currency forward contracts are valued using broker quotations or market transactions in either the listed or over-the-counter markets. As such, these derivative instruments are classified within Level 2.

Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

NOTE 16—Accumulated Other Comprehensive (Loss) Income:

The components and activity in Accumulated other comprehensive (loss) income (net of deferred income taxes) consisted of the following during the periods indicated below (in thousands):



	Foreign Currency Translation			Pension and Postretirement Benefits^(a)			Net Investment Hedge			Interest Rate Swap^(b)			Total
Three months ended March 31, 2017
Balance at December 31, 2016	$	(484,121	)	$	76		$	88,378		$	(16,745	)	$	(412,412	)
Other comprehensive income (loss) before reclassifications	79,055			—			(13,685		)	—			65,370
Amounts reclassified from accumulated other comprehensive loss	—			(7		)	—			529			522
Other comprehensive income (loss), net of tax	79,055			(7		)	(13,685		)	529			65,892
Other comprehensive income attributable to noncontrolling interests	(461		)	—			—			—			(461		)
Balance at March 31, 2017	$	(405,527	)	$	69		$	74,693		$	(16,216	)	$	(346,981	)
Three months ended March 31, 2016
Balance at December 31, 2015	$	(463,914	)	$	(758	)	$	62,245		$	(18,861	)	$	(421,288	)
Other comprehensive income (loss) before reclassifications	98,906			—			(9,524		)	—			89,382
Amounts reclassified from accumulated other comprehensive loss	—			1			—			525			526
Other comprehensive income (loss), net of tax	98,906			1			(9,524		)	525			89,908
Other comprehensive income attributable to noncontrolling interests	(283		)	—			—			—			(283		)
Balance at March 31, 2016	$	(365,291	)	$	(757	)	$	52,721		$	(18,336	)	$	(331,663	)


(a)	The pre-tax portion of amounts reclassified from accumulated other comprehensive loss consists of amortization of prior service benefit, which is a component of pension and postretirement benefits cost (credit). See Note 13, “Pension Plans and Other Postretirement Benefits.”


(b)	The pre-tax portion of amounts reclassified from accumulated other comprehensive loss is included in interest expense.

The amount of income tax (expense) benefit allocated to each component of Other comprehensive income (loss) for the three-month periods ended March 31, 2017 and 2016 is provided in the following tables (in thousands):



	Three Months Ended March 31,
	2017												2016
	Foreign Currency Translation			Pension and Postretirement Benefits			Net Investment Hedge			Interest Rate Swap			Foreign Currency Translation			Pension and Postretirement Benefits			Net Investment Hedge			Interest Rate Swap
Other comprehensive income (loss), before tax	$	80,141		$	(6	)	$	(21,580	)	$	834		$	99,277		$	4		$	(15,121	)	$	834
Income tax (expense) benefit	(1,086		)	(1		)	7,895			(305		)	(371		)	(3		)	5,597			(309		)
Other comprehensive income (loss), net of tax	$	79,055		$	(7	)	$	(13,685	)	$	529		$	98,906		$	1		$	(9,524	)	$	525

Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

NOTE 17—Related Party Transactions:

Our condensed consolidated financial statements include sales to and purchases from unconsolidated affiliates in the ordinary course of business as follows (in thousands):



	Three Months Ended March 31,
	2017		2016
Sales to unconsolidated affiliates	$	7,189	$	6,174
Purchases from unconsolidated affiliates	40,570		35,621

NOTE 18—Recently Issued Accounting Pronouncements:

In May 2014, the Financial Accounting Standards Board (“FASB”) issued accounting guidance designed to enhance comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets. The core principle of the guidance is that revenue recognized from a transaction or event that arises from a contract with a customer should reflect the consideration to which an entity expects to be entitled in exchange for goods or services provided. To achieve that core principle the new guidance sets forth a five-step revenue recognition model that will need to be applied consistently to all contracts with customers, except those that are within the scope of other topics in the ASC. Also required are new disclosures to help users of financial statements better understand the nature, amount, timing and uncertainty of revenues and cash flows from contracts with customers. The new disclosures include qualitative and quantitative information about contracts with customers, significant judgments made in applying the revenue guidance, and assets recognized related to the costs to obtain or fulfill a contract. In March 2016 and April 2016, the FASB issued amendments to this new guidance that provides clarification about principal versus agent considerations, identification of performance obligations and accounting for the licensing of intellectual property. In May 2016, the FASB issued an amendment to the guidance that provides clarification about collectibility, noncash consideration, presentation of sales tax, and transition. In December 2016, the FASB issued an amendment to the guidance that provides narrow-scope improvements and practical expedient regarding collectibility, presentation of sales tax collected from customers, non-cash considerations, contract modifications at transition, completed contracts at transition and other technical corrections. These new requirements become effective for annual and interim reporting periods beginning after December 15, 2017. Early adoption is permitted for annual and interim reporting periods beginning after December 15, 2016. We expect to adopt the new standard in the first quarter of 2018 using the modified retrospective method. We have made significant progress in evaluating our existing contracts and accounting policies to determine the impact this standard will have on the condensed consolidated financial statements and related disclosures.

In July 2015, the FASB issued accounting guidance that requires inventory to be measured at the lower of cost and net realizable value. The scope of this guidance excludes inventory measured using the last-in first-out method or the retail inventory method. This new requirement became effective on January 1, 2017 and did not have a significant impact on our condensed consolidated financial statements.

In February 2016, the FASB issued accounting guidance that requires assets and liabilities arising from leases to be recorded on the balance sheet. Additional disclosures are required regarding the amount, timing, and uncertainty of cash flows from leases. This new guidance will be effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, and is to be applied using a modified retrospective approach. Early adoption is permitted. The impact of this new requirement on our financial statements is being assessed and is not yet known.

In March 2016, the FASB issued accounting guidance that simplifies several aspects of the accounting for share-based payment awards. Among other things, this guidance requires all tax effects related to share-based payment awards to be recognized as income tax expense or benefit on the income statement, thus eliminating all additional paid-in capital pools. An entity should recognize excess tax benefits regardless of whether the benefit reduces income taxes payable in the current period. For interim reporting purposes, excess tax benefits and tax deficiencies should be accounted for as discrete items in the reporting period in which they occur. Additionally, this new guidance requires all tax related cash flows resulting from share-based payments to be presented as an operating activity on the statement of cash flows rather than as a financing activity. This guidance became effective on January 1, 2017. The impact of recognizing excess tax benefits in the income statement resulted in a $4.1 million reduction in Income tax expense for the three-month period ended March 31, 2017. The remaining aspects of adopting this guidance did not have a material impact on our condensed consolidated financial statements.

In August 2016, the FASB issued accounting guidance which clarifies the proper presentation and classification of certain cash receipts and cash payments in the statement of cash flows. The new guidance addresses cash flow issues including, but not

Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

limited to, debt prepayment or debt extinguishment costs and distributions received from equity method investments. As allowed by the provisions of this new guidance, we early-adopted this new guidance in the first quarter of 2017. The adoption of this new guidance did not have a significant impact on our condensed consolidated financial statements.

In November 2016, the FASB issued accounting guidance that requires restricted cash and restricted cash equivalents to be included with cash and cash equivalents when reconciling the beginning and end of period total amounts shown on the statement of cash flows. This guidance will be effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years, and is to be applied on a retrospective basis. Early adoption is permitted. We do not expect this guidance to have a significant impact on our financial statements.

In January 2017, the FASB issued accounting guidance to clarify the definition of a business for determining whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. This guidance will be effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years, and is to be applied on a prospective basis. Early adoption is permitted. We currently do not expect this guidance to have a significant impact on our financial statements.

In January 2017, the FASB issued accounting guidance to simplify the accounting for goodwill impairment. The guidance removes Step 2 of the goodwill impairment test, which requires a reporting unit to calculate the implied fair value of goodwill by assigning the fair value of a reporting unit to all of its assets and liabilities as if that reporting unit has been acquired in a business combination. A goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. All other goodwill impairment guidance will remain unchanged. Entities will continue to have the option to perform a qualitative assessment to determine if a quantitative impairment test is necessary. This guidance will be effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and is to be applied on a prospective basis. Early adoption is permitted for goodwill impairment tests performed after January 1, 2017. We do not expect this guidance to have a significant impact on our financial statements.

In March 2017, the FASB issued accounting guidance that changes the presentation of net periodic pension and postretirement benefit cost (“net benefit cost”) in the income statement. This new guidance requires service cost to be presented as part of operating income (expense) and all other components of net benefit cost are to be shown outside of operations. This guidance will be effective for periods beginning after December 15, 2017, including interim periods within those fiscal years, and is to be applied on a retrospective basis. Early adoption is permitted as of the beginning of an annual period for which an entity’s financial statements have not been issued or made available for issuance. We do not expect this guidance to have a significant impact on our financial statements.



Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Forward-looking Statements

Some of the information presented in this Quarterly Report on Form 10-Q, including the documents incorporated by reference, may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on our current expectations, which are in turn based on assumptions that we believe are reasonable based on our current knowledge of our business and operations. We have used words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “should,” “would,” “will” and variations of such words and similar expressions to identify such forward-looking statements.

These forward-looking statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict and many of which are beyond our control. Therefore, there can be no assurance that our actual results will not differ materially from the results and expectations expressed or implied in the forward-looking statements. Factors that could cause actual results to differ materially include, without limitation:


•	changes in economic and business conditions;


•	changes in financial and operating performance of our major customers and industries and markets served by us;


•	the timing of orders received from customers;


•	the gain or loss of significant customers;


•	competition from other manufacturers;


•	changes in the demand for our products or the end-user markets in which our products are sold;


•	limitations or prohibitions on the manufacture and sale of our products;

Table of Contents


•	availability of raw materials;


•	increases in the cost of raw materials and energy, and our ability to pass through such increases;


•	changes in our markets in general;


•	fluctuations in foreign currencies;


•	changes in laws and government regulation impacting our operations or our products;


•	the occurrence of regulatory proceedings, claims or litigation;


•	the occurrence of cyber-security breaches, terrorist attacks, industrial accidents, natural disasters or climate change;


•	hazards associated with chemicals manufacturing;


•	the inability to maintain current levels of product or premises liability insurance or the denial of such coverage;


•	political unrest affecting the global economy, including adverse effects from terrorism or hostilities;


•	political instability affecting our manufacturing operations or joint ventures;


•	changes in accounting standards;


•	the inability to achieve results from our global manufacturing cost reduction initiatives as well as our ongoing continuous improvement and rationalization programs;


•	changes in the jurisdictional mix of our earnings and changes in tax laws and rates;


•	changes in monetary policies, inflation or interest rates that may impact our ability to raise capital or increase our cost of funds, impact the performance of our pension fund investments and increase our pension expense and funding obligations;


•	volatility and uncertainties in the debt and equity markets;


•	technology or intellectual property infringement, including cyber-security breaches, and other innovation risks;


•	decisions we may make in the future;


•	the ability to successfully execute, operate and integrate acquisitions and divestitures; and


•	the other factors detailed from time to time in the reports we file with the SEC.

We assume no obligation to provide revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws. The following discussion should be read together with our condensed consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q.

The following is a discussion and analysis of results of operations for the three-month periods ended March 31, 2017 and 2016. A discussion of consolidated financial condition and sources of additional capital is included under a separate heading “Financial Condition and Liquidity” on page 32.

Overview

We are a leading global developer, manufacturer and marketer of highly-engineered specialty chemicals that meet customer needs across an exceptionally diverse range of end markets. The end markets we serve include the petroleum refining, consumer electronics, energy storage, construction, automotive, lubricants, pharmaceuticals, crop protection, food safety and custom chemistry services. We believe that our commercial and geographic diversity, technical expertise, innovative capability, flexible, low-cost global manufacturing base, experienced management team and strategic focus on our core base technologies will enable us to maintain leading market positions in those areas of the specialty chemicals industry in which we operate.

Secular trends favorably impacting demand within the end markets that we serve combined with our diverse product portfolio, broad geographic presence and customer-focused solutions will continue to be key drivers to our future earnings growth. We continue to build upon our existing green solutions portfolio and our ongoing mission to provide innovative, yet commercially viable, clean energy products and services to the marketplace. We believe our disciplined cost reduction efforts and ongoing productivity improvements position us well to take advantage of strengthening economic conditions as they occur while softening the negative impact of the current challenging global economic environment.

First Quarter 2017

During the first quarter of 2017:


•	We repaid the 3.00% Senior notes in full, €307.0 million of the 1.875% Senior notes and $174.7 million of the 4.50% Senior notes, as well as related tender premiums of $45.2 million, using a portion of the proceeds from the sale of the Chemetall Surface Treatment business.


•	We announced that Albemarle and Tianqi Lithium Corporation (“Tianqi”) terminated the option agreement for Tianqi to acquire a 20% indirect ownership interest in Rockwood Lithium GmbH, a wholly-owned German subsidiary of

Table of Contents

Albemarle, and its subsidiaries. As a result, we will retain 100% of the ownership interest in Rockwood Lithium GmbH.


•	We announced the approval for the expansion of lithium concentrate production at our Greenbushes, Australia site through our 50% owned Talison joint venture. Commissioning of the expansion is expected to begin in the second quarter of 2019 and would more than double the current lithium carbonate capacity.


•	We entered into a $250 million accelerated share repurchase (“ASR”) agreement, receiving and retiring an initial delivery of 1,948,178 shares of our common stock pursuant to the terms of the ASR agreement and our share repurchase program.


•	Our board of directors declared a quarterly dividend of $0.32 per share on February 23, 2017, which was paid on April 3, 2017 to shareholders of record at the close of business as of March 15, 2017.


•	Our net sales for the quarter were $722.1 million, up 10% from net sales of $657.2 million in the first quarter of 2016. Net sales from our reportable segments for the quarter were $689.0 million, an increase of 18% from net sales of $583.3 million in the first quarter of 2016.


•	Earnings per share were $0.45 (on a diluted basis), a decrease from first quarter 2016 results of $1.87 per diluted share from continuing operations.


•	Cash provided by operating activities was $82.6 million in the first quarter, a decrease from $172.7 million in the first quarter 2016.

Outlook

The current global business environment presents a diverse set of opportunities and challenges in the markets we serve, from slow and uneven global growth, currency exchange volatility, significantly lower crude oil prices, a dynamic pricing environment and an ever-changing landscape in electronics, to the continuous need for cutting edge catalysts and technology by our refinery customers, diverse energy storage needs including exciting opportunities in electric vehicles, and increasingly stringent environmental standards. Amidst these dynamics, we believe our business fundamentals are sound and that we are strategically well-positioned as we remain focused on increasing sales volumes, optimizing and improving the value of our portfolio through pricing and product development, managing costs and delivering value to our customers and shareholders. We believe that our businesses remain positioned to capitalize on new business opportunities and long-term trends driving growth within our end markets and to respond quickly to improved economic conditions.

Lithium and Advanced Materials: We expect continued strong growth for the remainder of 2017, led by strong underlying demand in battery-grade applications, increased lithium carbonate and hydroxide conversion capacity and continued price improvement in Lithium. PCS experienced weaker profitability in 2016 due to weakness in the curatives market and the bankruptcy filing of one of our customers which resulted in a $10 million impact to Income from continuing operations before income taxes and adjusted EBITDA during the year. While we expect further negative impacts from the bankruptcy filing in 2017, we expect PCS profitability to stabilize in 2017 due to productivity gains and increased volumes due to market demand, offset slightly by unfavorable pricing due to excess supply.

On a longer term basis, we believe that demand for lithium will continue to grow as new applications for lithium power continue to be developed and the use of plug-in hybrid electric vehicles and battery electric vehicles escalates. In addition, we expect growth in PCS from growing global demand for plastics driven by rising standards of living and infrastructure spending, particularly in Asia and the Middle East.

Bromine Specialties: The Bromine Specialties business got off to a strong start to 2017, with double digit year over year adjusted EBITDA growth in the first quarter driven by strong fire safety and other derivative volume increases and productivity improvements. While encouraged by the first quarter 2017 results, we are cautiously optimistic for the remainder of the year due to sustained low oil prices impacting our drilling fluids business and overall demand and supply economics in fire safety and other derivatives.

On a longer term basis, we continue to believe that improving global standards of living, widespread digitization, increasing demand for data management capacity and the potential for increasingly stringent fire safety regulations in developing markets are likely to drive continued demand for fire safety products. Absent an increase in regulatory pressure on offshore drilling, we would expect this business to follow a long-term growth trajectory once oil prices recover from recent levels as we expect that deep water drilling will continue to increase around the world. We are focused on profitably growing our globally competitive bromine and derivatives production network to serve all major bromine consuming products and markets. We believe the global supply/demand gap could tighten as demand for existing and possible new uses of bromine expands over time. The combination of solid, long-term business fundamentals, with our strong cost position, product

Table of Contents

innovations and effective management of raw material costs will enable us to manage our business through end market challenges and to capitalize on opportunities that are expected with favorable market trends in select end markets.

Refining Solutions: Following the downturn in 2015 (primarily caused by cash preservation measures from oil companies, triggered by oil price volatility), in 2016 we saw a significant increase in the number of “Hydro treating unit” catalyst change-outs and related catalyst demand. In addition to catalyst demand increase, we also saw a marked improvement in catalyst product mix year over year. Despite ongoing uncertainty of oil prices and the ensuing impact on crude slates used by refiners and resulting demand for catalysts, we expect sustained performance in our clean fuels technology business driven by refining change-outs and balanced product mix. We also expect solid performance from our Fluid Catalytic Cracking (“FCC”)division despite a number of scheduled maintenance shutdowns and plant turnarounds at refiners, which could dampen FCC demand in 2017. We also anticipate headwinds from rising input costs in 2017 following historically low prices in 2016.

On a longer term basis, we believe increased global demand for transportation fuels from a growing population and increasing mobility and the implementation of more stringent fuel quality requirements will drive growth in our Refining Solutions business. Delivering superior end-use performance continues to be the most effective way to create sustainable value in the refinery catalysts industry, and we believe our technologies continue to provide significant performance and financial benefits to refiners challenged to meet tighter regulations around the world, those managing new contaminants present in North America tight oil, and those in the Middle East and Asia seeking to use heavier feedstock while pushing for higher propylene yields. Longer term, we believe that the global crude supply will get heavier and more sour, a trend that bodes well for our catalysts portfolio. With superior technology and production capacities, and expected growth in end market demand, we believe that Refining Solutions remains well-positioned for the future.

All Other: During the first quarter of 2016, we closed the previously announced sales of the metal sulfides business and the minerals-based flame retardants and specialty chemicals business. The cash generated from the sale of these businesses was used to reduce borrowings outstanding under the September 2015 Term Loan Agreement. In April 2016, we concluded that we would suspend efforts to sell the fine chemistry services business. This business will continue to be reported outside the Company’s reportable segments. We expect the next few years to be a challenge for fine chemistry services due to a challenging agriculture industry environment, as well as customer order timing in pharmaceuticals.

Corporate: We continue to focus on cash generation, working capital management and process efficiencies. We expect our global effective tax rate for 2017 to be approximately 21.0%; however, our rate will vary based on the locales in which income is actually earned and remains subject to potential volatility from changing legislation in the U.S. and other tax jurisdictions. We also anticipate the potential for increased periodic volatility in future effective tax rates from the continuing impact of the Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2016-09, which was adopted in the first quarter of 2017.

In the first quarter of 2017, we increased our quarterly dividend rate to $0.32 per share. During the three months ended March 31, 2017, we received and retired approximately 1.9 million shares of our common stock under our share repurchase program and the ASR agreement. The total number of shares to ultimately be delivered under the ASR agreement will be determined upon completion of the ASR agreement, which will be by the end of the second quarter of 2017. In addition, following the completion of this ASR agreement, we may periodically repurchase shares in the future on an opportunistic basis as approved by our share repurchase program.

We remain committed to evaluating the merits of any opportunities that may arise for acquisitions or other business development activities that will complement our business footprint. Additional information regarding our products, markets and financial performance is provided at our website, www.albemarle.com. Our website is not a part of this document nor is it incorporated herein by reference.

Table of Contents

Results of Operations

The following data and discussion provides an analysis of certain significant factors affecting our results of operations during the periods included in the accompanying consolidated statements of income.

First Quarter 2017 Compared to First Quarter 2016

Selected Financial Data (Unaudited)



	Three Months Ended March 31,						Percentage Change
	2017			2016			2017 vs. 2016
	(In thousands, except percentages and per share amounts)
NET SALES	$	722,063		$	657,211		10	%
Cost of goods sold	466,975			414,677			13	%
GROSS PROFIT	255,088			242,534			5	%
GROSS PROFIT MARGIN	35.3		%	36.9		%
Selling, general and administrative expenses	108,001			82,631			31	%
Research and development expenses	24,323			19,872			22	%
Gain on sales of businesses, net	—			(121,324		)	(100	)%
Acquisition and integration related costs	—			18,558			(100	)%
OPERATING PROFIT	122,764			242,797			(49	)%
OPERATING PROFIT MARGIN	17.0		%	36.9		%
Interest and financing expenses	(68,513		)	(15,114		)	353	%
Other (expenses) income, net	(794		)	47			*
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES AND EQUITY IN NET INCOME OF UNCONSOLIDATED INVESTMENTS	53,457			227,730			(77	)%
Income tax expense	11,971			25,485			(53	)%
Effective tax rate	22.4		%	11.2		%
INCOME FROM CONTINUING OPERATIONS BEFORE EQUITY IN NET INCOME OF UNCONSOLIDATED INVESTMENTS	41,486			202,245			(79	)%
Equity in net income of unconsolidated investments (net of tax)	21,171			15,991			32	%
NET INCOME FROM CONTINUING OPERATIONS	62,657			218,236			(71	)%
Income from discontinued operations (net of tax)	—			17,312			(100	)%
NET INCOME	62,657			235,548			(73	)%
Net income attributable to noncontrolling interests	(11,444		)	(7,362		)	55	%
NET INCOME ATTRIBUTABLE TO ALBEMARLE CORPORATION	$	51,213		$	228,186		(78	)%
NET INCOME FROM CONTINUING OPERATIONS AS A PERCENTAGE OF NET SALES	8.7		%	33.2		%
Basic earnings per share:
Continuing operations	$	0.46		$	1.88		(76	)%
Discontinued operations	—			0.15			(100	)%
	$	0.46		$	2.03		(77	)%
Diluted earnings per share:
Continuing operations	$	0.45		$	1.87		(76	)%
Discontinued operations	—			0.15			(100	)%
	$	0.45		$	2.02		(78	)%

*Percentage calculation is not meaningful.

Table of Contents

Net Sales

For the three-month period ended March 31, 2017, we recorded net sales of $722.1 million, an increase of $64.9 million, or 10%, compared to net sales of $657.2 million for the three-month period ended March 31, 2016. Net sales increased due to $86.0 million of higher volumes resulting from market demand and $8.8 million of favorable price impacts, partially offset by $3.8 million of unfavorable currency exchange impacts and $26.1 million related to the divested minerals-based flame retardants and specialty chemicals business.

Gross Profit

For the three-month period ended March 31, 2017, our gross profit increased $12.6 million, or 5%, from the corresponding 2016 period. Included in Costs of goods sold for the three-month period ended March 31, 2017 are: (1) a $10.6 million charge related to the markup of inventory purchased as part of the acquisition of the lithium hydroxide and lithium carbonate conversion business of Jiangxi Jiangli New Materials Science and Technology Co. Ltd. (“Jiangli New Materials”); (2) $8.9 million of acquisition and integration related costs resulting from the Jiangli New Materials acquisition; and (3) restructuring costs of $2.9 million related to a plan to reduce costs at several locations. In addition, gross profit decreased $1.6 million related to the divested minerals-based flame retardants and specialty chemicals business. Excluding the impact of these items, gross profit increased by $36.6 million, or 15%, due primarily to higher overall sales volumes and $8.8 million in favorable price impacts. Overall, these factors contributed to a lower gross profit margin for the three-month period ended March 31, 2017 of 35.3%, down from 36.9% in the corresponding period in 2016. Excluding the impact of the charges noted above, gross profit margin was 38.4% for the three-month period ended March 31, 2017 as compared to 38.2% in the corresponding period in 2016.

Selling, General and Administrative Expenses

For the three-month period ended March 31, 2017, our selling, general and administrative (“SG&A”) expenses increased $25.4 million, or 31%, from the three-month period ended March 31, 2016. The three-month period ended March 31, 2017 includes $5.4 million of acquisition and integration related costs, primarily resulting from the acquisition of Jiangli New Materials and $4.2 million of restructuring costs related to our Lithium site in Germany. Excluding the impact of these charges, SG&A increased $15.8 million primarily due to increased compensation related costs and professional fees. As a percentage of net sales, SG&A expenses were 15.0% for the three-month period ended March 31, 2017, compared to 12.6% for the corresponding period in 2016.

Research and Development Expenses

For the three-month period ended March 31, 2017, our research and development (“R&D”) expenses increased $4.5 million, or 22%, from the three-month period ended March 31, 2016. Included in R&D expenses for the three-month period ended March 31, 2017 are $5.8 million of restructuring costs related to our Lithium site in Germany. As a percentage of net sales, R&D expenses were 3.4% and 3.0% for the three-month periods ended March 31, 2017 and 2016, respectively.

Gain on Sales of Businesses, Net

In the first quarter of 2016, we closed the sales of the metal sulfides and the minerals-based flame retardants and specialty chemicals businesses and recorded gains before income taxes of $11.5 million and $111.3 million, respectively. In addition, Gain on sales of businesses, net, for the first quarter of 2016 includes a loss of $1.5 million on the sale of our wafer reclaim business.

Acquisition and Integration Related Costs

The three-month period ended March 31, 2016 included $16.9 million of integration costs resulting from the acquisition of Rockwood Holdings, Inc. (mainly consisting of professional services and advisory fees, costs to achieve synergies, relocation costs, and other integration costs) and $1.7 million of costs in connection with other significant projects. Acquisition and integration related costs for the three-month period ended March 31, 2017 are reported in Cost of goods sold and SG&A, as noted above.

Interest and Financing Expenses

Interest and financing expenses for the three-month period ended March 31, 2017 increased $53.4 million to $68.5 million from the corresponding 2016 period, due mainly to a loss on early extinguishment of debt of $52.8 million related to the tender premiums, fees, unamortized discounts and unamortized deferred financings costs from the repayment of the 3.00% Senior notes in full, €307.0 million of the 1.875% Senior notes and $174.7 million of the 4.50% Senior notes.

Other (Expenses) Income, Net

Other (expenses) income, net, for the three-month period ended March 31, 2017 was ($0.8) million compared to less than $0.1 million for the corresponding 2016 period. The change was primarily due to an increase in foreign exchange losses of $4.8

Table of Contents

million, $3.2 million of asset retirement obligation charges related to the revision of an estimate at a site formerly owned by Albemarle and a loss of $2.1 million associated with the previous disposal of a business, partially offset by a $7.4 million gain related to the acquisition of the remaining 50% interest of an equity investment in 2017.

Income Tax Expense

The effective income tax rate for the first quarter of 2017 was 22.4% compared to 11.2% for the first quarter of 2016. Our effective income tax rate differs from the U.S. Federal statutory income tax rates in the comparative periods primarily due to the impact of earnings from outside the U.S, and is mainly attributable to our share of the income of our Jordan Bromine Company Limited (“JBC”) joint venture, a Free Zones company under the laws of the Hashemite Kingdom of Jordan. In addition, Income tax expense for the three-month period ended March 31, 2017 included a $5.1 million out-of-period adjustment due to an changes in our deferred tax liabilities for basis differences in Chilean fixed assets, partially offset by a $4.1 million reduction from the tax effects of share-based compensation awards. Our effective tax rate for the three-month period ended March 31, 2016 was driven down by a variety of factors, primarily low tax gains from the sale of the minerals-based flame retardant business, as well as a favorable mix of earnings in lower tax jurisdictions.

Equity in Net Income of Unconsolidated Investments

Equity in net income of unconsolidated investments was $21.2 million for the three-month period ended March 31, 2017 compared to $16.0 million in the same period last year. Equity in net income of unconsolidated investments for the three-month period ended March 31, 2017 increased by $5.2 million primarily due to higher equity income reported by our Lithium and Advanced Materials segment joint venture Windfield Holdings Pty. Ltd. resulting from higher sales volumes.

Income from Discontinued Operations

The three-month period ended March 31, 2016 includes income from discontinued operations, after income taxes, of $17.3 million related to our Chemetall Surface Treatment business which was sold in the fourth quarter of 2016.

Net Income Attributable to Noncontrolling Interests

For the three-month period ended March 31, 2017, net income attributable to noncontrolling interests was $11.4 million compared to $7.4 million in the same period last year. This increase of $4.0 million was due primarily to an increase in consolidated income related to our Jordanian joint venture from higher sales volumes.

Net Income Attributable to Albemarle Corporation

Net income attributable to Albemarle Corporation decreased to $51.2 million in the three-month period ended March 31, 2017, from $228.2 million in the three-month period ended March 31, 2016. The decrease is primarily due to gains on sales of businesses and income from discontinued operations in 2016, as well as a loss on early extinguishment of debt related to the repayment of senior notes, restructuring costs and a higher effective tax rate in 2017. This was partially offset by higher gross profit associated with stronger business results and increased equity from net income of unconsolidated investments.

Other Comprehensive Income, Net of Tax

Total other comprehensive income, after income taxes, was $65.9 million for the three-month period ended March 31, 2017 compared to $89.9 million for the corresponding period in 2016. The majority of these amounts are the result of translating our foreign subsidiary financial statements from their local currencies to U.S. Dollars. In the 2017 period, other comprehensive income from foreign currency translation adjustments was $79.1 million, mainly as a result of favorable movements in the European Union Euro of approximately $57 million and the Korean Won of approximately $11 million and a net favorable variance in various other currencies totaling approximately $11 million (each approximately $4 million or less). Also included in total other comprehensive income for the 2017 period is a loss of $13.7 million in connection with the revaluation of our €700.0 million senior notes which have been designated as a hedge of our net investment in foreign operations. In the 2016 period, other comprehensive income from foreign currency translation adjustments was $98.9 million, mainly as a result of favorable movements in the European Union Euro of approximately $58 million, the British Pound Sterling of approximately $23 million, the Brazilian Real of approximately $6 million and a net favorable variance in various other currencies totaling approximately $12 million (each approximately $2 million or less). Also included in total other comprehensive income for the 2016 period is a loss of $9.5 million in connection with the revaluation of our €700.0 million senior notes which have been designated as a hedge of our net investment in foreign operations.

Segment Information Overview. We have identified three reportable segments according to the nature and economic characteristics of our products as well as the manner in which the information is used internally by the Company’s chief operating decision maker to evaluate performance and make resource allocation decisions. Our reportable business segments consist of: (1) Lithium and Advanced Materials, (2) Bromine Specialties and (3) Refining Solutions.

Table of Contents

Summarized financial information concerning our reportable segments is shown in the following tables. The “All Other” category comprises three operating segments that do not fit into any of our core businesses subsequent to the acquisition of Rockwood: minerals-based flame retardants and specialty chemicals, fine chemistry services and metal sulfides. During the first quarter of 2016, we completed the sales of the metal sulfides business and the minerals-based flame retardants and specialty chemicals business.

The Corporate category is not considered to be a segment and includes corporate-related items not allocated to the reportable segments. Pension and OPEB service cost (which represents the benefits earned by active employees during the period) and amortization of prior service cost or benefit are allocated to the segments, All Other, and Corporate, whereas the remaining components of pension and OPEB benefits cost or credit (“Non-operating pension and OPEB items”) are included in Corporate. Segment data includes intersegment transfers of raw materials at cost and allocations for certain corporate costs.



	Three Months Ended March 31,										Percentage Change
	2017			%		2016			%		2017 vs. 2016
	(In thousands, except percentages)
Net sales:
Lithium and Advanced Materials	$	284,375		39.4	%	$	216,173		32.9	%	32	%
Bromine Specialties	219,191			30.4	%	196,553			29.9	%	12	%
Refining Solutions	185,412			25.7	%	170,579			26.0	%	9	%
All Other	32,419			4.4	%	72,089			10.9	%	(55	)%
Corporate	666			0.1	%	1,817			0.3	%	(63	)%
Total net sales	$	722,063		100.0	%	$	657,211		100.0	%	10	%

Adjusted EBITDA:
Lithium and Advanced Materials	$	120,022		56.8	%	$	86,474		45.0	%	39	%
Bromine Specialties	68,488			32.4	%	61,608			32.1	%	11	%
Refining Solutions	49,579			23.5	%	55,074			28.7	%	(10	)%
All Other	5,156			2.4	%	8,464			4.4	%	(39	)%
Corporate	(31,869		)	(15.1	)%	(19,587		)	(10.2	)%	63	%
Total adjusted EBITDA	$	211,376		100.0	%	$	192,033		100.0	%	10	%

Table of Contents



	Lithium and Advanced Materials			Bromine Specialties		Refining Solutions		Reportable Segments Total			All Other			Corporate			Consolidated Total
Three months ended March 31, 2017
Net income (loss) attributable to Albemarle Corporation	$	94,106		$	58,694	$	40,474	$	193,274		$	3,246		$	(145,307	)	$	51,213
Depreciation and amortization	22,743			9,794		9,105		41,642			1,910			1,518			45,070
Utilization of inventory markup^(a)	10,606			—		—		10,606			—			—			10,606
Restructuring and other^(b)	—			—		—		—			—			12,905			12,905
Gain on acquisition^(c)	(7,433		)	—		—		(7,433		)	—			—			(7,433		)
Acquisition and integration related costs^(d)	—			—		—		—			—			14,281			14,281
Interest and financing expenses^(e)	—			—		—		—			—			68,513			68,513
Income tax expense	—			—		—		—			—			11,971			11,971
Non-operating pension and OPEB items	—			—		—		—			—			(1,063		)	(1,063		)
Other^(f)	—			—		—		—			—			5,313			5,313
Adjusted EBITDA	$	120,022		$	68,488	$	49,579	$	238,089		$	5,156		$	(31,869	)	$	211,376
Three months ended March 31, 2016
Net income (loss) attributable to Albemarle Corporation	$	63,327		$	51,853	$	46,314	$	161,494		$	130,709		$	(64,017	)	$	228,186
Depreciation and amortization	23,147			9,755		8,760		41,662			612			1,335			43,609
(Gain) loss on sales of businesses, net^(g)	—			—		—		—			(122,857		)	1,533			(121,324		)
Acquisition and integration related costs^(h)	—			—		—		—			—			18,558			18,558
Interest and financing expenses	—			—		—		—			—			15,114			15,114
Income tax expense	—			—		—		—			—			25,485			25,485
Income from discontinued operations (net of tax)	—			—		—		—			—			(17,312		)	(17,312		)
Non-operating pension and OPEB items	—			—		—		—			—			(283		)	(283		)
Adjusted EBITDA	$	86,474		$	61,608	$	55,074	$	203,156		$	8,464		$	(19,587	)	$	192,033

(a)

(b)


(c)	Gain recorded in Other (expenses) income, net related to the acquisition of the remaining 50% interest in Salmag. See Item 1 Financial Statements – Note 2, “Acquisitions,” for additional information.

(d)


(e)	Included in Interest and financing expenses is a loss on early extinguishment of debt of $52.8 million. See Item 1 Financial Statements – Note 10, “Long-term Debt,” for additional information.


(f)	Included in Other (expenses) income, net are $3.2 million of asset retirement obligation charges related to the revision of an estimate at a site formerly owned by Albemarle and a loss of $2.1 million associated with the previous disposal of a business.


(g)	See “Gain on Sales of Businesses, Net” on page 28 for a description of these items.


(h)	See “Acquisition and Integration Related Costs” on page 28 for a description of these items.

Lithium and Advanced Materials

Lithium and Advanced Materials segment net sales for the three-month period ended March 31, 2017 were $284.4 million, up $68.2 million, or 32%, in comparison to the same period in 2016. The increase was primarily driven by $53.0 million of favorable Lithium battery grade sales volumes due to market demand and $29.1 million of favorable Lithium price

Table of Contents

impacts due primarily to price increases in our battery grade lithium carbonate and hydroxide applications. This is partially offset by $11.7 million of unfavorable PCS volumes and price impacts primarily due to weakness in the organometallics segment and the bankruptcy filing of one of our customers, as well as $2.2 million of unfavorable currency translation impacts. Adjusted EBITDA for Lithium and Advanced Materials was up 39%, or $33.5 million, to $120.0 million for the three-month period ended March 31, 2017, compared to the same period in 2016, primarily due to higher overall sales volumes and favorable pricing, partially offset by $1.6 million of unfavorable currency translation impacts.

Bromine Specialties

Bromine Specialties segment net sales for the three-month period ended March 31, 2017 were $219.2 million, up $22.6 million, or 12%, in comparison to the same period in 2016. The increase was driven mainly by $26.2 million of higher sales volumes due to market demand and was partially offset by $3.5 million unfavorable price impacts. Adjusted EBITDA for Bromine Specialties was up 11%, or $6.9 million, to $68.5 million for the three-month period ended March 31, 2017, compared to the same period in 2016, primarily due to higher overall sales volumes and partially offset by unfavorable pricing and higher variable and fixed costs.

Refining Solutions

Refining Solutions segment net sales for the three-month period ended March 31, 2017 were $185.4 million, an increase of $14.8 million, or 9%, compared to the three-month period ended March 31, 2016. This increase was primarily due to $21.1 million of higher volumes from market conditions, partially offset by $3.7 million unfavorable impacts due to customer and product mix and $1.5 million of unfavorable currency exchange impacts. Refining Solutions adjusted EBITDA decreased 10%, or $5.5 million, to $49.6 million for the three-month period ended March 31, 2017 in comparison to the corresponding period of 2016. This decrease was primarily due to unfavorable mix impacts and higher costs, partially offset by $1.1 million of favorable currency translation impacts.

All Other

On February 1, 2016, we closed the sale of the minerals-based flame retardants and specialty chemicals business. The divestiture of this business reduced net sales and adjusted EBITDA for the first quarter of 2016 as compared to the prior year period by $26.1 million and $2.1 million, respectively.

All Other net sales for the three-month period ended March 31, 2017 were $32.4 million, a decrease of $39.7 million, or 55%, compared to the three-month period ended March 31, 2016. Excluding the impact of the divested business noted above, All Other net sales decreased by $13.5 million due to unfavorable fine chemistry services pricing impacts due to a contract formula change which did not impact earnings and lower sales volumes. All Other adjusted EBITDA was down 39%, or $3.3 million, for the three-month period ended March 31, 2017 in comparison to the corresponding period of 2016. Excluding the impact of the divested business noted above, All Other adjusted EBITDA decreased by $1.1 million due to unfavorable pricing impacts for fine chemistry services.

Corporate

Corporate adjusted EBITDA was a loss of $31.9 million for the three-month period ended March 31, 2017, compared to a loss of $19.6 million for the corresponding period of 2016. The change was primarily due to unfavorable currency impact $4.8 million and increased compensation costs.

Financial Condition and Liquidity

Overview

The principal uses of cash in our business generally have been capital investments, funding working capital, acquisitions and repayment of debt. We also make contributions to our defined benefit pension plans, pay dividends to our shareholders and repurchase shares of our common stock. Historically, cash to fund the needs of our business has been principally provided by cash from operations, debt financing and equity issuances.

We are continually focused on working capital efficiency particularly in the areas of accounts receivable and inventory. We anticipate that cash on hand, cash provided by operating activities and long-term borrowings will be sufficient to pay our operating expenses, satisfy debt service obligations, fund capital expenditures and other investing activities, fund pension contributions and pay dividends for the foreseeable future.

Table of Contents

Cash Flow

During the first three months of 2017, cash on hand, cash provided by operations and net borrowings of $66.4 million funded $751.2 million of debt repayments, a $250.0 million accelerated share repurchase program, $54.1 million of capital expenditures for plant, machinery and equipment, and dividends to shareholders of $34.3 million. Our operations provided $82.6 million of cash flows during the first three months of 2017, as compared to $172.7 million for the first three months of 2016. Our cash from operations included an outflow from working capital changes of $63.3 million, primarily due the increase in receivables from higher sales in certain regions with longer payment terms. Overall, our cash and cash equivalents decreased by approximately $1.02 billion to $1.25 billion at March 31, 2017, down from $2.27 billion at December 31, 2016.

During the three-month period ended March 31, 2017, using a portion of the proceeds from the sale of the Chemetall Surface Treatment business, we repaid the 3.00% Senior notes in full, €307.0 million of the 1.875% Senior notes and $174.7 million of the 4.50% Senior notes, as well as related tender premiums of $45.2 million.

Under our existing Board authorized share repurchase program, the Company entered into an ASR agreement with a financial institution on March 1, 2017. Under the ASR agreement, in March 2017, the Company paid $250 million from available cash on hand and received and retired an initial delivery of 1,948,178 shares of our common stock with a fair market value of $200 million, which reduced the Company’s weighted average shares outstanding for purposes of calculating basic and diluted earnings per share for the three-month period ended March 31, 2017. The total number of shares to ultimately be delivered under the ASR agreement will be determined upon completion of the ASR agreement, which will be by the end of the second quarter of 2017, and will generally be based on the daily Rule 10b-18 volume-weighted average prices of the Company’s common stock over the term of the ASR agreement, less an agreed discount. As of March 31, 2017, there were 13,051,822 remaining shares available for repurchase under the Company’s authorized share repurchase program.

Capital expenditures for the three-month period ended March 31, 2017 of $54.1 million, were associated with property, plant and equipment additions. We expect our capital expenditures to approximate $350 to $400 million in 2017 for Lithium growth and capacity increases, productivity and continuity of operations projects. Of the total capital expenditures, our projects related to the continuity of operations is expected to remain in the range of 4-6% of net sales, similar to prior years.

Net current assets were $1.18 billion and $2.17 billion at March 31, 2017 and December 31, 2016, respectively, with the decrease being largely due to the reduction in cash used to repay a portion of the senior notes and to fund the accelerated share repurchase program during first quarter of 2017. Other changes in the components of net current assets are due to the timing of the sale of goods and other normal transactions leading up to the balance sheet dates and are not the result of any policy changes by the Company, and do not reflect any change in either the quality of our net current assets or our expectation of success in converting net working capital to cash in the normal course of business.

On February 23, 2017, we increased our quarterly dividend rate to $0.32 per share, a 5% increase from the quarterly rate of $0.305 per share paid in 2016.

At March 31, 2017 and December 31, 2016, our cash and cash equivalents included $895.2 million and $846.4 million, respectively, held by our foreign subsidiaries. The majority of these foreign cash balances are associated with earnings that we have asserted are indefinitely reinvested and which we plan to use to support our continued growth plans outside the U.S. through funding of capital expenditures, acquisitions, research, operating expenses or other similar cash needs of our foreign operations. From time to time, we repatriate cash associated with earnings from our foreign subsidiaries to the U.S. for normal operating needs through intercompany dividends, but only from subsidiaries whose earnings we have not asserted to be indefinitely reinvested or whose earnings qualify as “previously taxed income” as defined by the Internal Revenue Code. For the three-month period ended March 31, 2016, we repatriated approximately $0.4 million of cash as part of these foreign earnings cash repatriation activities. No such repatriations occurred during the three-month period ended March 31, 2017.

While we continue to closely monitor our cash generation, working capital management and capital spending in light of continuing uncertainties in the global economy, we believe that we will continue to have the financial flexibility and capability to opportunistically fund future growth initiatives. Additionally, we anticipate that future capital spending including business acquisitions, share repurchases and other cash outlays should be financed primarily with cash flow provided by operations and cash on hand, with additional cash needed, if any, provided by borrowings. The amount and timing of any additional borrowings will depend on our specific cash requirements.

Table of Contents

Long-Term Debt

We currently have the following senior notes outstanding:



Issue Month/Year	Principal (in millions)	Interest Rate	Interest Payment Dates		Maturity Date
December 2014	€393.0	1.875%	December 8		December 8, 2021
November 2014	$425.0	4.15%	June 1	December 1	December 1, 2024
November 2014	$350.0	5.45%	June 1	December 1	December 1, 2044
December 2010	$175.3	4.50%	June 15	December 15	December 15, 2020

Our senior notes are senior unsecured obligations and rank equally with all our other senior unsecured indebtedness from time to time outstanding. The senior notes are effectively subordinated to any of our existing or future secured indebtedness and to the existing and future indebtedness of our subsidiaries. As is customary for such long-term debt instruments, each senior note outstanding has terms that allow us to redeem the notes before its maturity, in whole at any time or in part from time to time, at a redemption price equal to the greater of (i) 100% of the principal amount of the senior notes to be redeemed, or (ii) the sum of the present values of the remaining scheduled payments of principal and interest thereon (exclusive of interest accrued to the date of redemption) discounted to the redemption date on a semi-annual basis using the comparable government rate (as defined in the indentures governing the senior notes) plus between 25 and 40 basis points, depending on the note, plus, in each case, accrued interest thereon to the date of redemption. Holders may require us to purchase such notes at 101% upon a change of control triggering event, as defined in the indentures. The senior notes are subject to typical events of default, including bankruptcy and insolvency events, nonpayment and the acceleration of certain subsidiary indebtedness of $40 million or more caused by a nonpayment default.

Our revolving, unsecured credit agreement dated as of February 7, 2014, as amended, (the “February 2014 Credit Agreement”) currently provides for borrowings of up to $1.0 billion and matures on February 7, 2020. Borrowings bear interest at variable rates based on the LIBOR for deposits in the relevant currency plus an applicable margin which ranges from 1.000% to 1.700%, depending on the Company’s credit rating from Standard & Poor’s Ratings Services, Moody’s Investors Services and Fitch Ratings. The applicable margin on the facility was 1.300% as of March 31, 2017. There were no borrowings outstanding under the February 2014 Credit Agreement as of March 31, 2017.

Borrowings under the February 2014 Credit Agreement are conditioned upon compliance with the following covenants: (a) consolidated funded debt, as defined in the agreement, must be less than or equal to 3.50 times consolidated EBITDA, as defined in the agreement, which reflects adjustments for certain non-recurring or unusual items such as restructuring charges, facility divestiture charges and other significant non-recurring items (herein “consolidated adjusted EBITDA” or “adjusted EBITDA”) as of the end of any fiscal quarter; (b) with the exception of certain liens as specified in the agreement, liens may not attach to assets when the aggregate amount of all indebtedness secured by such liens plus unsecured subsidiary indebtedness, other than indebtedness incurred by our subsidiaries under the February 2014 Credit Agreement, would exceed 20% of consolidated net worth, as defined in the agreement; and (c) with the exception of certain indebtedness as specified in the agreement, subsidiary indebtedness may not exceed the difference between 20% of consolidated net worth, as defined in the agreement, and indebtedness secured by liens permitted under the agreement.

On May 29, 2013, we entered into agreements to initiate a commercial paper program on a private placement basis under which we may issue unsecured commercial paper notes (the “Commercial Paper Notes”) from time-to-time up to a maximum aggregate principal amount outstanding at any time of $750.0 million. The proceeds from the issuance of the Commercial Paper Notes are expected to be used for general corporate purposes, including the repayment of other debt of the Company. Our February 2014 Credit Agreement is available to repay the Commercial Paper Notes, if necessary. Aggregate borrowings outstanding under the February 2014 Credit Agreement and the Commercial Paper Notes will not exceed the $1.0 billion current maximum amount available under the February 2014 Credit Agreement. The Commercial Paper Notes will be sold at a discount from par, or alternatively, will be sold at par and bear interest at rates that will vary based upon market conditions at the time of issuance. The maturities of the Commercial Paper Notes will vary but may not exceed 397 days from the date of issue. The definitive documents relating to the commercial paper program contain customary representations, warranties, default and indemnification provisions. At March 31, 2017, we had $314.5 million of Commercial Paper Notes outstanding bearing a weighted-average interest rate of approximately 1.54% and a weighted-average maturity of 29 days. The Commercial Paper Notes are classified as Current portion of long-term debt in our condensed consolidated balance sheets at March 31, 2017 and December 31, 2016.

The non-current portion of our long-term debt amounted to $1.40 billion at March 31, 2017, compared to $2.12 billion at December 31, 2016. In addition, at March 31, 2017, we had the ability to borrow $685.5 million under our commercial paper program and the February 2014 Credit Agreement, and $224.3 million under other existing lines of credit, subject to various

Table of Contents

financial covenants under our February 2014 Credit Agreement. We have the ability and intent to refinance our borrowings under our other existing credit lines with borrowings under the February 2014 Credit Agreement, as applicable. Therefore, the amounts outstanding under those credit lines, if any, are classified as long-term debt. We believe that as of March 31, 2017, we were, and currently are, in compliance with all of our debt covenants.

Off-Balance Sheet Arrangements

In the normal course of business with customers, vendors and others, we have entered into off-balance sheet arrangements, including bank guarantees and letters of credit, which totaled approximately $47.1 million at March 31, 2017. None of these off-balance sheet arrangements has, or is likely to have, a material effect on our current or future financial condition, results of operations, liquidity or capital resources.

Other Obligations

Total expected 2017 contributions to our domestic and foreign qualified and nonqualified pension plans, including our SERP, should approximate $10 million. We may choose to make additional pension contributions in excess of this amount. We have made contributions of $2.4 million to our domestic and foreign pension plans (both qualified and nonqualified) during the three-month period ended March 31, 2017.

The liability related to uncertain tax positions, including interest and penalties, recorded in Other noncurrent liabilities totaled $26.3 million at March 31, 2017 and $27.9 million at December 31, 2016. Related assets for corresponding offsetting benefits recorded in Other assets totaled $13.8 million at March 31, 2017 and $15.1 million at December 31, 2016. We cannot estimate the amounts of any cash payments associated with these liabilities for the remainder of 2017 or the next twelve months, and we are unable to estimate the timing of any such cash payments in the future at this time.

We are subject to federal, state, local and foreign requirements regulating the handling, manufacture and use of materials (some of which may be classified as hazardous or toxic by one or more regulatory agencies), the discharge of materials into the environment and the protection of the environment. To our knowledge, we are currently complying and expect to continue to comply in all material respects with applicable environmental laws, regulations, statutes and ordinances. Compliance with existing federal, state, local and foreign environmental protection laws is not expected to have a material effect on capital expenditures, earnings or our competitive position, but the costs associated with increased legal or regulatory requirements could have an adverse effect on our results.

Among other environmental requirements, we are subject to the federal Superfund law, and similar state laws, under which we may be designated as a potentially responsible party (“PRP”) and may be liable for a share of the costs associated with cleaning up various hazardous waste sites. Management believes that in cases in which we may have liability as a PRP, our liability for our share of cleanup is de minimis. Further, almost all such sites represent environmental issues that are quite mature and have been investigated, studied and in many cases settled. In de minimis situations, our policy generally is to negotiate a consent decree and to pay any apportioned settlement, enabling us to be effectively relieved of any further liability as a PRP, except for remote contingencies. In other than de minimis PRP matters, our records indicate that unresolved PRP exposures should be immaterial. We accrue and expense our proportionate share of PRP costs. Because management has been actively involved in evaluating environmental matters, we are able to conclude that the outstanding environmental liabilities for unresolved PRP sites should not have a material adverse effect upon our results of operations or financial condition.

Liquidity Outlook

We anticipate that cash on hand and cash provided by operating activities and borrowings will be sufficient to pay our operating expenses, satisfy debt service obligations, fund any capital expenditures and share repurchases, make acquisitions, make pension contributions and pay dividends for the foreseeable future. Our main focus over the next three years, in terms of uses of cash, will be investing in growth of the businesses and the return of value to shareholders. Additionally, we will continue to evaluate the merits of any opportunities that may arise for acquisitions of businesses or assets, which may require additional liquidity.

Our cash flows from operations may be negatively affected by adverse consequences to our customers and the markets in which we compete as a result of moderating global economic conditions and reduced capital availability.

While we maintain business relationships with a diverse group of financial institutions, an adverse change in their credit standing could lead them to not honor their contractual credit commitments, decline funding under existing but uncommitted lines of credit, not renew their extensions of credit or not provide new financing. While the global corporate bond and bank loan markets remain strong, periods of elevated uncertainty related to global economic and/or geopolitical concerns may limit efficient access to such markets for extended periods of time. If such concerns heighten, we may incur increased borrowing costs and reduced credit capacity as our various credit facilities mature. When the U.S. Federal Reserve or similar national

Table of Contents

reserve banks in other countries decide to tighten the monetary supply in response, for example, to improving economic conditions, we may incur increased borrowing costs as interest rates increase on our variable rate credit facilities, as our various credit facilities mature or as we refinance any maturing fixed rate debt obligations.

Overall, with generally strong cash-generative businesses and no significant long-term debt maturities before 2020, we believe we have and will maintain a solid liquidity position.

We had cash and cash equivalents totaling $1.25 billion as of March 31, 2017, of which $895.2 million is held by our foreign subsidiaries. This cash represents an important source of our liquidity and is invested in short-term investments including time deposits and readily marketable securities with relatively short maturities. The cash held by our foreign subsidiaries is intended for use outside of the U.S. We anticipate that any needs for liquidity within the U.S. in excess of our cash held in the U.S. can be readily satisfied with borrowings under our existing U.S. credit facilities or our commercial paper program.

Recent Accounting Pronouncements

For a description of recent accounting pronouncements, see Item 1 Financial Statements – Note 18, “Recently Issued Accounting Pronouncements.”



Item 3.	Quantitative and Qualitative Disclosures About Market Risk.

There have been no significant changes in our interest rate risk, foreign currency exchange rate exposure, marketable securities price risk or raw material price risk from the information we provided in our Annual Report on Form 10-K for the year ended December 31, 2016.

We had variable interest rate borrowings of $353.3 million outstanding at March 31, 2017, bearing a weighted average interest rate of 1.48% and representing approximately 20% of our total outstanding debt. A hypothetical 10% change (approximately 15 basis points) in the interest rate applicable to these borrowings would change our annualized interest expense by approximately $0.5 million as of March 31, 2017. We may enter into interest rate swaps, collars or similar instruments with the objective of reducing interest rate volatility relating to our borrowing costs.

Our financial instruments which are subject to foreign currency exchange risk consist of foreign currency forward contracts with an aggregate notional value of $285.9 million and with a fair value representing a net asset position of less than $0.1 million at March 31, 2017. Fluctuations in the value of these contracts are generally offset by the value of the underlying exposures being hedged. We conducted a sensitivity analysis on the fair value of our foreign currency hedge portfolio assuming an instantaneous 10% change in select foreign currency exchange rates from their levels as of March 31, 2017, with all other variables held constant. A 10% appreciation of the U.S. Dollar against foreign currencies that we hedge would result in a decrease of approximately $15.6 million in the fair value of our foreign currency forward contracts. A 10% depreciation of the U.S. Dollar against these foreign currencies would result in an increase of approximately $12.9 million in the fair value of our foreign currency forward contracts. The sensitivity of the fair value of our foreign currency hedge portfolio represents changes in fair values estimated based on market conditions as of March 31, 2017, without reflecting the effects of underlying anticipated transactions. When those anticipated transactions are realized, actual effects of changing foreign currency exchange rates could have a material impact on our earnings and cash flows in future periods.



Item 4.	Controls and Procedures.

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act), as of the end of the period covered by this report. Based on this evaluation, our principal executive officer and principal financial officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

No change in our internal control over financial reporting (as such term is defined in Exchange Act Rule 13a-15(f)) occurred during the first quarter ended March 31, 2017 that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II. OTHER INFORMATION



Item 1.	Legal Proceedings.

We are involved from time to time in legal proceedings of types regarded as common in our business, including administrative or judicial proceedings seeking remediation under environmental laws, such as Superfund, products liability, breach of contract liability and premises liability litigation. Where appropriate, we may establish financial reserves for such proceedings. We also maintain insurance to mitigate certain of such risks. Additional information with respect to this Item 1 is contained in Note 11 to the Notes to the Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q.



Item 1A.	Risk Factors.

While we attempt to identify, manage and mitigate risks and uncertainties associated with our business to the extent practical under the circumstances, some level of risk and uncertainty will always be present. The risk factors set forth in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2016 describes some of the risks and uncertainties associated with our business. These risks and uncertainties have the potential to materially affect our results of operations and our financial condition. We do not believe that there have been any material changes to the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2016.



Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.

The following table summarizes our repurchases of equity securities for the three-month period ended March 31, 2017:



Period	Total Number of Shares Repurchased	Average Price Paid Per Share		Total Number of Shares Repurchased as Part of Publicly Announced Plans or Programs^(a)	Maximum Number of Shares that May Yet Be Repurchased Under the Plans or Programs
January 1, 2017 to January 31, 2017	—	$	—	—	15,000,000
February 1, 2017 to February 28, 2017	—	—		—	15,000,000
March 1, 2017 to March 31, 2017^(b)	1,948,178	102.66		1,948,178	13,051,822
Total	1,948,178	$	102.66	1,948,178	13,051,822

(a)

Our stock repurchase plan, which was authorized by our Board of Directors, became effective on October 25, 2000 and included ten million shares. Since then, the Company has regularly repurchased shares under the stock repurchase plan, resulting in the Board of Directors periodically authorizing additional shares for repurchase under the plan. On November 3, 2016, our Board of Directors authorized another increase in the number of shares, pursuant to which the Company is now permitted to repurchase up to a maximum of fifteen million shares under the plan, including those shares previously authorized, but not yet repurchased. The stock repurchase plan will expire when we have repurchased all shares authorized for repurchase thereunder, unless the stock repurchase plan is earlier terminated by action of our Board of Directors or further shares are authorized for repurchase.


(b)	In the first quarter of 2017, we paid $250 million under an ASR Agreement, receiving and retiring an initial delivery of 1,948,178 shares. The Average Price Paid Per Share was calculated using the closing price per share of our common stock the date the ASR Agreement was signed. See Note 7, “Earnings Per Share,” to the condensed consolidated financial statements included in this report.

Table of Contents



Item 6.	Exhibits.

(a) Exhibits



31.1			Certification of Chief Executive Officer pursuant to Rule 13a-14(a).

31.2			Certification of Chief Financial Officer pursuant to Rule 13a-14(a).

32.1			Certification of Chief Executive Officer pursuant to Rule 13a-14(b) and 18 U.S.C. Section 1350.

32.2			Certification of Chief Financial Officer pursuant to Rule 13a-14(b) and 18 U.S.C. Section 1350.

101			Interactive Data File (Quarterly Report on Form 10-Q, for the quarterly period ended March 31, 2017, furnished in XBRL (eXtensible Business Reporting Language)).

Attached as Exhibit 101 to this report are the following documents formatted in XBRL: (i) the Consolidated Statements of Income for the three months ended March 31, 2017 and 2016, (ii) the Consolidated Statements of Comprehensive Income for the three months ended March 31, 2017 and 2016, (iii) the Condensed Consolidated Balance Sheets at March 31, 2017 and December 31, 2016, (iv) the Consolidated Statements of Changes in Equity for the three months ended March 31, 2017 and 2016, (v) the Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2017 and 2016 and (vi) the Notes to the Condensed Consolidated Financial Statements.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.




		ALBEMARLE CORPORATION
		(Registrant)

Date:	May 3, 2017	By:	/S/ SCOTT A. TOZIER
			Scott A. Tozier
			Executive Vice President and Chief Financial Officer
			(principal financial officer)

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company